HLA-B27
 
 
 
Ankylosing Spondylitis
 
 
 
Videos
 
 
 
Glossary
 
 
 
Exercises
 
 
 
Books
 
 
 
Other Publications
 
 
 
Other Resources
 
 
 
Curriculum Vitae
 
 
 
About us
 
 
 
Consultation
 
 
 
 Curriculum Vitae     June 20, 2019  


Info/Buy

Secure Checkout

Personal information is secured with SSL technology.

Free Shipping

Free global shipping
No minimum order.

Description

Focusing on the key essentials you need to know, Axial Spondyloarthritisprovides a quick, expert overview of axSpA from a clinical perspective. This concise resource by Drs. Philip Mease and Muhammad Khan presents practical recommendations and guidelines for the diagnosis, management, and treatment of spondyloarthritis impacting the axial skeleton alongside an overview of epidemiology, special populations, and patient education.

Table of Contents

  1. Introduction
    2. Clinical Features, Physical Findings and Diagnosis of Axial Spondyloarthritis
    3. Epidemiology of Axial Spondyloarthritis
    4. Classification Criteria for Axial Spondyloarthritis
    5. Genetics of Axial Spondyloarthritis
    6. The Gut Microbiome and Ankylosing Spondylitis 
    7. Pathogenesis of Ankylosing Spondylitis
    8. Bone Pathophysiology in Axial Spondyloarthritis
    9. Clinical Assessment of Axial Spondyloarthritis
    10. Imaging in Axial Spondyloarthritis
    11. Extra-articular Manifestations: Uveitis, Colitis, Psoriasis
    12. Co-morbidities
    13. Non-Pharmacological Management of Axial Spondyloarthritis
    14. Pharmacological Non-Biologic Management of Axial Spondyloarthritis
    15. Biologic Treatment of Axial Spondyloarthritis
    16. Treatment Guidelines for Axial Spondyloarthritis
    17. Economic Evaluations in Axial Spondyloarthritis
    18. Patient Education and Patient Service Organizations

Details

No. of pages:
 
304
Language:
 
English
Copyright:
© Elsevier 2019
Published:
 
Imprint:
 
Elsevier
eBook ISBN:
 
9780323568012
Paperback ISBN:
 
9780323568005

About the Author

Philip Mease

Affiliations and Expertise

Rheumatologist, Seattle Rheumatology Associates, Internal Medicine and Rheumatology; Seattle, WA, United States

Muhammad Khan

Affiliations and Expertise

Professor Emeritus of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH.

Axial Spondyloarthritis - 1st Edition - ISBN: 9780323568005, 9780323568012

BIOGRAPHICAL SKETCH (Curriculum Vitae)

Minimize

MUHAMMAD ASIM KHAN, MD, FRCP, MACP, MACR

Academic Title:  Professor Emeritus of Medicine,

                        Case Western Reserve University School of Medicine, Cleveland, OH

Address: Office:  MetroHealth Medical Center, Department of Medicine, Division of                  
  Rheumatology, 2500 MetroHealth Drive, Cleveland, OH 44109-1998

E-mail            :  m.asimkhan@gmail.com

Phone No      :  (216) 778‑8704               Fax No:  (216) 778-8376

Citizenship    :  U.S.A.


FACULTY APPOINTMENTS:  

All at Case Western Reserve University (CWRU) School of Medicine, Cleveland, OH:

·       Senior Instructor in Medicine July 1, 1973 ‑ June 30, 1974       

·       Assistant Professor of Medicine July 1, 1974 ‑ June 30, 1981;

·       Associate Professor of Medicine July 1, 1981 ‑ June 30, 1989 

·       Awarded Tenure on July 1, 1983

·        Professor of Medicine since July 1, 1989

·        Professor Emeritus of Medicine since July 1, 2012         

                                

AWARDS and HONORS:


§  Elected Master of the American College of Rheumatology (MACR) in 2009

§  Elected Master of the American College of Physicians (MACP) in 2003

§  Distinguished Rheumatologist Award from the American College of Rheumatology in 2000 (Note: This reward is now renamed “Distinguished Clinician Scholar Award”)

          §  Professor Emeritus of Medicine award by the Case Western Reserve University in 2012

§  Inducted into Medical Hall of Honor of MetroHealth Medical Center in 2014

§  Elected Fellow of the Royal College of Physicians (FRCP) in 1988

§  Elected Fellow of the American College of Physicians (FACP) in 1978

§  Lifetime of Dedication and Devotion to People with Spondylitis Award from the Spondylitis Association of America (SAA) in 1998

-          Also the first recipient of the SAA’s Greg Field Award in 2005 (“Given to individuals with ankylosing spondylitis who have persevered and gone on to be of service to others”)

§  Lifetime Achievement Award from the Spondyloarthritis Research and Treatment Network (SPARTAN) in 2013 (“For a lifetime of commitment and success in advancing spondyloarthritis treatment and research”)

§  Lifetime Achievement Award from the Ohio Association of Rheumatology (OAR) in 2015


         § 
Teaching Excellence Awards from MetroHealth Medical Center in 2006 and 2011

§  Named to the “Best Doctors in America” (Nationally) 2005 to 2012

§  Award from King Edward Medical College Alumni Association of North America:

Distinguished Alumnus Award of Academic Excellence in 1998


   §      Awards from King Edward Medical College, Lahore, Pakistan:

1962 - Neil Memorial Silver Medal for 1st position in Anatomy

1964- Burton Brown Silver Medal for 1st position in Physiology

           1964 - Raghbir Sahai Memorial Prize for 1st position in Surgery‑Minor


   §      Pakistan Army Medical Corps Service Medal in 1966 (Army Service 1965 – 1967)


LICENSURE:  

                 

State Medical Board, State of Ohio (FLEX), August 1973

BOARD CERTIFICATIONS:

¨     American Board of Internal Medicine, June 1972

¨     Royal College of Physicians, London, England (MRCP), January 1973

¨     American Board of Internal Medicine, Subspecialty of Rheumatology, October 1974

GRADUATE EDUCATION:

Pre‑medical degree (FSc), July 1960, Government College, Punjab University,      Lahore, Pakistan

Medical degree (MBBS), August 1965, King Edward Medical College, Punjab University, Lahore

POST‑GRADUATE TRAINING:

I.                 In Pakistan:

Military Service: Active military duty from 1965 – 1966; Captain, Pakistan Army Medical Corps

Senior House Officer, Medicine: Mayo Hospital, Lahore, November 1966 ‑ June 1967

II.              In the United Kingdom:


Senior House Officer, Orthopedics and Trauma: Highlands General Hospital, Winchmore Hill, London; August 1967 ‑ January 1968


House Officer, Internal Medicine: Rush Green Hospital, Romford, Essex, February 1968 ‑ August 1968


Senior House Officer, Internal Medicine: St. Mary's Hospital, Isle of Wight, August 1968 ‑ June 1969

III.             In the United States of America:


First Year Internal Medicine Residency, 1969 – 1970; Lakewood Hospital, Lakewood, OH


Second Year Internal Medicine Residency, 1970 – 1971, VA Hospital, CWRU, Cleveland, OH


Third Year Resident in Internal Medicine; Subspecialty ‑ Rheumatology, 1971 – 1972, at Cleveland Metropolitan General Hospital (CMGH) / CWRU, Cleveland. [CMGH is now renamed MetroHealth Medical Center (MHMC)].

Robert M. Stecher Fellow in Rheumatology, 1972 – 1973, CMGH / CWRU, Cleveland,

MEMBERSHIP IN PROFESSIONAL ORGANIZATIONS:

American College of Rheumatology; Master

Royal College of Physicians, London; Fellow

Cleveland Rheumatism Society

Honorary Life Member of: Pakistan Society for Rheumatology

British Society for Rheumatology (from 1996 to 2006)

Founding Member of:

       ASAS (Assessment of SpondyloArthritis International Society),

       SPARTAN (Spondyloarthritis Research and Treatment Network), and

       GRAPPA (Group for Research and Assessment of Psoriasis and Psoriatic Arthritis)

ADVISORY BOARD & Other Advisory Roles:

·         National Advisory Board for National Institute of Arthritis and Musculoskeletal and Skin Disorders (NIAMS): Member from 1992 to 1995

·         Spondylitis Association of America (SAA): Medical and Scientific Advisory Board since 1986, Chairman 1991‑93  

·         Assessment of SpondyloArthritis international Society (ASAS); formerly called “Assessment of Ankylosing Spondylitis”: Founding Member since its inception in1995; and Member Advisory Board from 2002 to 2010.

·         Spondyloarthritis Research and Treatment Network (SPARTAN): Member of the Steering Committee from 2003 to 2011. Member Education Committee since 2014. Member Board of Directors from 2015 to 2018.

·         International Congress of Spondyloarthropathies Meetings (Ghent, Belgium): Member of the Scientific Committee from 2000-2014.

·         Pharmaceutical Companies: Various roles, such as member of Medical Advisory Boards, speaker, consultant, clinical studies, member Safety Monitoring Committee, etc.

EDITORIAL BOARD:

·        Current Rheumatology Reports: Section Editor, Spondyloarthritis (Previously “Seronegative Arthritis”)

·        SN Comprehensive Clinical Medicine: Editorial Board Member

·        UpToDate: Peer Reviewer from 2016

·        Rheumatology Editorial Consultant to “ACP Smart Medicine” (formerly called Physician Information and Education Resource or “PIER”), from June 2002 till 2015 when this on-line education resource of the American College of Physicians was discontinued.

·        Rheumatology Editorial Consultant to InPractice, an on-line education resource for internists and rheumatologists, from its inception in 2013 till 2016 when it was discontinued.

·        International Journal of Clinical Rheumatology. Editorial Board: International Editor

·        Medscape Editorial Board: Advisor

·        Value-Based Care in Rheumatology: Member Advisory Editorial Board since 2012

·        Revista Latinoamericana de Psoriasis y Artritis: Member of the Editorial Board 

·        Previous Editorial Board memberships: 

       Current Opinion in Rheumatology: Section Editor for 9 years (from 1993 to 2001)

       Joint Bone Spine till 2010

       Clinical Rheumatology till 2010

       International Journal of Clinical Rheumatology (previously Future Rheumatology) till 2015


EDITORIAL REVIEWER
:

Arthritis and Rheumatism         

Journal of Rheumatology

Annals of Rheumatic Diseases

Nature Reviews Rheumatology

PLOS ONE

Arthritis Research & Therapy

Joint Bone Spine

Rheumatology

Clinical Rheumatology

Clinical and Experimental Rheumatology

Scandinavian Journal of Rheumatology

Journal of Clinical Rheumatology

Annals of Internal Medicine

American Journal of Medicine

Archives of Internal Medicine

AMERICAN COLLEGE OF RHEUMATOLOGY (ACR):

¨      Awarded the ACR’s Distinguished Rheumatologist Award in 2000.

¨      Elected a Master (MACR) by the ACR in 2009.

¨      ACR Annual Meeting Planning Committee Member: From 2001 to 2004.

¨      ACR Clinical Review Course Organizer and Moderator, from 2002 to 2004.

¨      ACR Annual Scientific Meetings Abstract Selection Committee Member (Subsection Spondyloarthropathies) for 20 years (from 1984 to 1995; and in 1999, 2001, 2006 and, 2008).

¨      “Meet the Professor" sessions at the ACR Annual Scientific Meetings for 7 years (in Boston 1991; Atlanta 1992; San Antonio 1993; Minneapolis 1994; Washington, DC 2006; Boston 2007 and San Francisco  2008).

¨      "Meet the Professor" session and Speaker, Annual State-of-the-Art (SOTA) ACR Clinical Symposium, Chicago, IL, April 26 – 27, 2014

¨      Started the Spondyloarthropathy Study Group at the ACR Annual Meetings in 1992 and chaired the first two meetings (1992 and 1993).

¨      Council Member, ACR Central Region: from 1993 to 1996.   

AMERICAN COLLEGE OF PHYSICIANS:

Elected a Master of the American College of Physician (MACP) in 2003; MACP is the highest category of membership in the ACP, the second largest physician group in the U.S.

·        Editorial Consultant since June 2002 to American College of Physicians’ on-line ACP Smart Medicine (formerly called Physician Information and Education Resource or“PIER”). Author of the chapter “Ankylosing Spondylitis” and its updates since 2002 till 2015 when this on-line education resource was discontinued.

Assisted in preparation of Rheumatology MKSAP (Medical Knowledge Self-Assessment Program), 2nd Edition 1997, and wrote the chapters on ‘Spondyloarthropathies’, and ‘Axial Pain Syndromes: Back and Neck Pain’.

National Institute of Health, NIAMS, FDA:

[NIAMS = NATIONAL INSTITUTE of ARTHRITIS and MUSCULOSKELETAL SKIN DISORDERS. FDA = FOOD and DRUG ADMINISTRATION]

·           Invited speaker, Spondyloarthritis 2006: The Unmet Needs Conference, sponsored by NIAMS and the Spondylitis Association of America, held at the NIH campus, Bethesda, Maryland on March 30-31, 2006.

·           Faculty Member, Development of a Guidance Document on Ankylosing Spondylitis Meeting (request from the FDA); Bethesda, Maryland, October 30-31, 2002.

·           Member, NIH Study Section Review of R01 R21 RFA AR-00-008 (Spondyloarthropathies: New Approach to Pathogenesis), July 18, 2001.

·           Invited participant, “Ankylosing Spondylitis Research: HLA-B27 and Beyond”, sponsored by the National Institute of Arthritis and Musculoskeletal and Skin Disorders (NIAMS) and the Spondylitis Association of America, held at the NIH campus, Bethesda, Maryland on September 1-2, 1998.

·           Member, National Advisory Board for NIAMS from 1992 to 1995.

·           Invited participant in the Workshop on Clinical Investigations/Trials in Rheumatology, held at the NIH campus in Bethesda, Maryland on February 4, 1992.

·           Invited participant (by NIAMS), in the Symposium and Workshop on Spondyloarthropathies and HLA‑B27, organized by the Institute of Rheumatology of the Russian Academy of Medicine, held at St. Petersburg, Russia, October 27‑31, 1992. Consultant, Institute of Rheumatology, Moscow, Russia, November 2‑5, 1992 (under U.S.‑Russia Cooperative Program on Arthritis & Musculoskeletal Diseases).

·           Advisor to the NIAMS project "US/USSR Epidemiological Studies of the Spondyloarthropathies in Circumpolar Populations," Seward, Alaska, June 3-5, 1991.

·           Invited participant in the NIAMS Workshop on Studies of the Rheumatic Diseases in Pima Indians, Phoenix, Arizona on October 31, 1991.

·           Invited participant in the NIAMS Meeting of the "US/USSR Epidemiological Studies of the Spondyloarthropathies in Circumpolar Populations," Boston, Massachusetts, November 21‑22, 1991.

·           Member of the Planning Committee for the Workshop on Immunogenetics of the Rheumatic Diseases, June 21‑22, 1988; NIH, Bethesda, MD. Chairperson of the session on Spondyloarthropathies. Proceedings published in Am J Med (Suppl. 6A):1‑61, 1988.

·           Chairperson of the Workgroup on Spondylitic Disorders at Prevention Conference on Arthritis, sponsored by National Arthritis Advisory Board (co‑sponsoring agencies = NIADDK & Dept. of Defense).  Held at Airlie House, Warrenton, Virginia, July 19‑22, 1983.

Spondylitis Association of America:


  • The first recipient of the Spondylitis Association of America’s Greg Field Award in 2005. This award is given to “individuals with ankylosing spondylitis who have persevered and gone on to be of service to others”.
  • Received an award from SAA in 1998 for “A lifetime of dedication and devotion to people with spondylitis.”
  • Chairman of the SAA Medical and Scientific Advisory Board from 1991 to`1993
  • Member of the SAA Medical and Scientific Advisory Board since 1986. 


Spondyloarthritis Research Organizations: ASAS, SPARTAN andGRAPPA

Founding Member of all of these three professional research organizations for spondyloarthritis:

ASAS: Assessment in SpondyloArthritis international Society

SPARTAN: SpondyloArthritis Research and Treatment Network

GRAPPA: Group for Research and Assessment of Psoriasis and Psoriatic Arthritis

International Congress on Spondyloarthopathies:

Member of the Scientific Committee from 1998 till 2014



Arthritis Foundation:

§  Wrote the chapters on Ankylosing Spondylitis in the Primer on Rheumatic Diseases; 10th Edition (1993) and 11th Editions (1997).

§  Helped revise Medical Information Series booklet on Ankylosing Spondylitis (2nd Edition, 1987).

RESEARCH INTERESTS:

       Clinical and genetic studies of ankylosing spondylitis (AS) and related spondyloarthropathies (SpA)

        HLA-B27 immunogenetics

        Clinical and genetic studies of rheumatoid arthritis and other diseases

       Early diagnosis and effective management of rheumatic diseases


        [Most of the research was funded primarily by the Irma Bender Arthritis Research Fund]

SCIENTIFIC PUBLICATIONS:

BOOKS:

Author:

·         Khan MA: ANKYLOSING SPONDYLITIS: THE FACTS. Oxford University Press, Oxford, UK, 2002; pp.1-193.

·         Portuguese translation was published in 2004

·         Japanese translation was published in 2008

·         Persian (Farsi) translation was published in 2008

·         Spanish translation was published in 2012

·         Khan MA: ANKYLOSING SPONDYLITIS. Oxford University Press, New York, NY. 2009; pp. 1-147.

·         Khan MA: ANKYLOSING SPONDYLITIS-AXIAL SPONDYLOARTHRITIS.  Professional Communications, Inc. (PCI). West Islip, NY. November  2016, pp. 1-333.

 ISBN: 978-1-943236-08-4

Editor:

·         Khan MA (Editor): Ankylosing spondylitis and related Spondyloarthropathies.  Spine: State of the Art Reviews. Hanley & Belfus, Inc., Philadelphia, PA. September 1990

·    Mease P, Khan MA (Co-Editors): Axial Spondyloarthritis. Elseviers. 2019 (In preparation)

Guest Editor:


·    Khan MA: Guest Editor. Spondyloarthropathies.  Rheumatic Disease Clinics of North America. Saunders, Philadelphia, PA. February 1992


·    Khan MA: Guest Editor. Ankylosing Spondylitis: Burden of Illness; Diagnosis, and Effective Treatment.  J Rheumatol Suppl 2006; Sep;78:1-33


Section Editor

 

·    Khan MA: Section Editor. Spondyloarthropathies. Current Opinion in Rheumatology Lippincott Williams and Wilkins, Hagerstown M.                                                                                           From 1993 to 2001.

·    Khan MA: Section Editor. Spondyloarthritis. Current Rheumatology Reports, Springer-Nature Since 2006.


Editorial Consultant


·    Khan MA: Editorial Consultant to American College of Physicians’ on-line ACP Smart Medicine (formerly called Physician Information and Education Resource or“PIER”). Author of the chapter “Ankylosing Spondylitis” and its updates since from 2002 to 2015.

·    Khan MA: Editorial Consultant to InPractice Rheumatology, an on-line knowledge source for internists, and other specialists, including rheumatologists. Co-author of the chapter on “Spondyloarthritis 2013 – 2016..                                                                      

Other publications:

50   Book chapters 

238 Scientific articles

140 Scientific abstracts

 37  Letters-to-editor

BOOK CHAPTERS:

    1.        Khan MA:  Family studies in rheumatoid arthritis.  In Dawkins RL, Christiansen FT and Zilko PJ (Eds.):  IMMUNOGENETICS IN RHEUMATOLOGY, Amsterdam, Excerpta Medica, 1982, pp. 139‑141.

    2.        Khan MA:  B27 and ankylosing spondylitis in different races.  In Dawkins RL, Christiansen FT and Zilko PJ (Eds.):  IMMUNOGENETICS IN RHEUMATOLOGY, Amsterdam, Excerpta Medica, 1982, pp. 188‑190.

    3.        Khan MA:  Ankylosing spondylitis.  In Calin A (Ed.):  SPONDYLARTHROPATHIES, New York, Grune and Stratton, 1984, pp. 69‑117.

    4.        Khan MA:  Spondyloarthropathies in non‑Caucasians.  In Calin A (Ed.): SPONDYLARTHROPATHIES, New York, Grune and Stratton, 1984, pp. 265‑277.

    5.        Khan MA:  How the B27 test can help in the diagnosis of spondyloarthropathies. In: Calin A (Ed.):  SPONDYLARTHROPATHIES, New York, Grune and Stratton, 1984, pp. 323‑337.

    6.        Khan MA, Kushner I:  Diagnosis of ankylosing spondylitis.  In Cohen AS (Ed.): PROGRESS IN CLINICAL RHEUMATOLOGY, VOL. I, New York, Grune and Stratton, 1984, pp. 145‑178.

    7.        Khan MA, Kammer G:  Laboratory findings and pathology of psoriatic arthritis. In: Gerber LH and Espinoza L (Eds.):  PSORIATIC ARTHRITIS, New York, Grune and Stratton, 1985, pp. 109‑124.

    8.        Khan MA: Spondyloarthropathies in non‑Caucasian populations of the world. In: Ziff M, Cohen SB (Eds.): THE SPONDYLOARTHROPATHIES (ADVANCES IN INFLAMMATION RESEARCH, VOL. 9), New York, Raven Press, 1985, pp. 91‑99.

    9.        Khan MA: HLA and ankylosing spondylitis.  In Calabro JJ, Dick C (Eds.): ANKYLOSING SPONDYLITIS‑NEW CLINICAL APPLICATIONS IN RHEUMATOLOGY, VOL. I, Lancaster (England), MTP Press Limited, 1987, pp. 23‑44.

10.        Khan MA, Skosey JL:  Ankylosing spondylitis and related spondyloarthropathies. In Samter M, Talmage DW, Frank MM, Austen KF, Claman HN (Eds.): IMMUNOLOGICAL DISEASES, 4th Edition, Boston, Little, Brown & Company, 1988, pp. 1509‑1538.

11.        Khan MA, Reynolds TL:  Genetische aspekte and HLA‑B27 bei der spondylitis ankylosans.  In Fellmann N, Spring H (Eds.):  SPONDYLITIS ANKYLOSANS MORBUS BECHTEREW, Bern, Verlag Hans Huber, 1989, pp. 48‑56.

12.        Yamashita TS, Khan MA, Reynolds TL, Wolfe F, Stastny P:  Familial rheumatoid arthritis:  Genetic epidemiology of 75 white multi‑case families.  In Dupont B (Ed.): IMMUNOBIOLOGY OF HLA, Vol II: IMMUNOGENETICS AND HISTO-COMPATIBILITY, New York, Springer‑Verlag, 1989, pp. 419‑420.

13.        Stastny P, Olsen N, Pincus T, Khan MA, Ball EJ:  DR4 and DR1 define different subsets of patients with rheumatoid arthritis.  In Dupont B (Ed.):  IMMUNOBIOLOGY OF HLA, VOL II: IMMUNOGENETICS AND HISTOCOMPATIBILITY, New York, Springer‑Verlag, 1989, pp. 418‑419.

14.        Khan MA:  Heterogeneity and a wider spectrum of ankylosing spondylitis and related disorders.  In Lipsky PE and Taurog JD (Eds.):  HLA‑B27+ SPONDYLOARTHROPATHIES, New York, Elsevier, 1991, pp. 133‑143.

15.        Khan MA:  Ankylosing spondylitis.  In Schumacher HR Jr. (Ed.):  PRIMER ON THE RHEUMATIC DISEASES, (10th Edition), Atlanta, Arthritis Foundation, 1993, pp. 154-158.

16.        van der Linden SM, Khan MA:  Spondyloarthropathies.  In Wigley RD (Ed.): THE PRIMARY PREVENTION OF RHEUMATIC DISEASES, New York, The Parthenon Publishing Group, 1993, pp. 221-228.

17.        Khan MA:  Ankylosing spondylitis: Clinical features.  In Klippel JH, Dieppe PA (Eds.): RHEUMATOLOGY, London, Mosby-Year Book Europe Ltd., 1994, pp. 3.25.1 - 3.25.10

18.        Khan MA:  Ankylosing spondylitis.  In Rakel RE (Ed.):  CONN'S CURRENT THERAPY, 1994 Edition, Philadelphia, W. B. Saunders Co., 1994, pp. 957-959.

19.        Khan MA:  Ankylosing spondylitis: Clinical features.  In Klippel JH, Dieppe PA (Eds.): RHEUMATOLOGY, London, Mosby-Year Book Europe Ltd., 1995, pp. 211-220.

20.        Khan MA, Wilber RG:  Back and neck pain. In Bone R (Ed.):  CURRENT PRACTICE OF MEDICINE, Philadelphia, Current Medicine, 1996, pp. VI:8.1-VI:8.14.

21.        Khan MA. Prevalence of HLA-B27 in world populations. In Lopez-Larrea C (Ed.): HLA-B27 IN THE DEVELOPMENT OF SPONDYLOARTHROPATHIES. Austin, Texas, R.G. Landes Company, 1997, pp.95-112.

22.        Khan MA: Spondyloarthropathies.  RHEUMATOLOGY MKSAP (Medical Knowledge Self-Assessment Program), Second Edition, Developed by the American College of Rheumatology and the American College of Physicians, 1997, pp. 126-139.

23.        Khan MA: Axial pain syndromes: Back and neck pain. RHEUMATOLOGY MKSAP (Medical Knowledge Self-Assessment Program), 2nd Edition, Developed by the American College of Rheumatology and the American College of Physicians, 1997, pp. 258-266.

24.        Khan MA:  Ankylosing spondylitis.  PRIMER ON THE RHEUMATIC DISEASES, 11th Edition, Atlanta,  Arthritis Foundation, 1997, pp. 189-193.

25.        Khan MA:  Ankylosing spondylitis: Clinical features.  In Klippel JH, Dieppe PA (Eds.): RHEUMATOLOGY, (2nd Edition). London, Mosby-Wolfe, 1998, pp. 6.16.1- 6.16.10.

26.        Khan MA: Seronegative spondyloarthropathies. In: Home HS, Feng PH (Eds). TEXTBOOK OF CLINICAL RHEUMATOLOGY, National Arthritis Foundation, Singapore. 1998, pp. 125-147.

27.        Dougados M, Revel M, Khan MA: Management of spondyloarthropathy. In: van de Putte   LBA, Williams HJ, van Riel P, Furst DE (Eds): THERAPY OF SYSTEMIC RHEUMATIC DISORDERS. New York, Marcel Dekker, 1998, pp. 375-406.

28.        Khan MA: A worldwide overview - The epidemology of HLA-B27 and associated spondyloarthritides. In: Calin A, Taurog J (Eds.): THE SPONDYLARTHRITIDES. Oxford University Press, 1998, pp. 17-26.

29.        Khan MA:  Ankylosing spondylitis - The clinical aspects. In: Calin A, Taurog J (Eds.): THE SPONDYLARTHRITIDES. Oxford, Oxford University Press, 1998, pp. 27-40. 

30.        Khan MA: Spondyloarthropathies. In: Hunder G (Ed): ATLAS OF RHEUMATOLOGY. Philadelphia, Current Science, 1998, pp. 5.1 - 5.24.

31.        Khan MA: Back and neck pain. In: Fitzgerald F (Ed.): CURRENT PRACTICE OF MEDICINE, 2nd Edition, Philadelphia, Current Medicine, 1999, pp. 187-203.

32.        Khan MA: Ankylosing spondylitis.  In: Rakel RE (Ed.): CONN'S CURRENT THERAPY, 1999 Edition, Philadelphia, W. B. Saunders Co., 1999, pp. 994 - 996.

33.        Khan MA, McGonagle D. State of the art review: Pathogenesis of ankylosing spondylitis and related spondyloarthropathies. In Emery P (Ed.). FAST FACTS IN RHEUMATOLOGY Oxford, Health Press, 1999, pp.61-66.

34.        Braun J, Sieper J, Khan MA. Recent Advances in Pharmacotherapy of Spondyloarthropathies. In: Tsokos GC, Kammer GM, Moreland LW, Pelletier J, Gay S. (Eds.). Modern Therapeutics in Rheumatic Diseases. Humana Press, Totowa, New Jersey, 2002, pp. 595-603.

35.        Khan MA. Five classical clinical papers on ankylosing spondylitis. In Dieppe P, Wollheim FA, Schumacher HR (Eds.). CLASSICAL PAPERS IN RHEUMATOLOGY. Martin Dunitz Ltd., London, 2002, pp. 118-133.

36.        Khan MA: HLA-B27 und seine Subtypen. In: Braun J & Sieper J (Eds.) SPONDYLITIS ANKYLOSANS. Unimed Verlag AG, Bremen [German Edition] 2002, pp. 64-69.

37.        Khan MA: Spondyloarthropathies. In: Hunder G (Ed.). ATLAS OF RHEUMATOLOGY. 3rd Edition. Philadelphia, PA: Current Medicine 2002, pp.141–167.

38.        Khan MA: Clinical features of ankylosing spondylitis: In: Hochberg M, Silman A, Smolen J, Weinblatt M, Weisman M (Editors). RHEUMATOLOGY, (3rd Edition). London, Mosby: A Division of Harcourt Health Sciences Ltd. 2003, pp. 1161-1181.

39.        Khan MA, Sieper J. Reactive arthritis. In: Koopman WJ and Moreland LW (Editors). ARTHRITIS AND ALLIED CONDITIONS. (15th Edition), Lippincott Williams and Wilkins 2004, pp. 1335-1355.

40.        Khan MA: Spondyloarthropathies. In: Hunder G (Ed.). ATLAS OF RHEUMATOLOGY. 4th Edition. Philadelphia, PA: Current Medicine 2005, pp. 151-180.

41.        Akkoc N, Khan MA.  Epidemiology of ankylosing spondylitis and related spondyloarthropathies. In: Weisman MH, Reveille JD, van der Heijde D. (Eds.), ANKYLOSING SPONDYLITIS AND THE SPONDYLOARTHROPATHIES: A Companion to Rheumatology. London, Mosby:- Elsevier: 2006, pp. 117-131.

42.        Khan MA: Patient’s perspective. In: van Royen BJ and Dijkmans BAC (Eds.). ANKYLOSING SPONDYLITIS DIAGNOSIS AND MANAGEMENT. New York, NY: Taylor and Francis. 2006, pp. 95-97.

43.        Elyan M, Khan MA. Spondyloarthropathies. CLINICAL CARE IN THE RHEUMATIC DISEASES. 3rd ed. Atlanta: Association of Rheumatology Health Professionals. 2006, pp. 177-185.

44.        Khan, MA. HLA and spondyloarthropathies. Chapter 16. In Mehra NK (Ed). The HLA Complex in Biology and Medicine A Resource Book. Jaypee Brothers Medical Publishers Ltd. New Delhi, India. 2010: pp. 259-275.

45.        Elyan M, Khan MA. Spondyloarthropathies. In Lin VW (Ed). Spinal Cord Medicine: Principles and Practice, Second Edition. Demos Medical Publishing, New York, NY. 2010: pp. 715-727.

46.        Khan MA. Clinical features of axial spondylorthritis. In: Oxford Textbook of Acial Spondyloarthritis  Inman R, Sieper J, eds. Oxford University Press, Oxford, UK. 2016: pp. 91-100.

47.        Khan MA. Clinical features, diagnosis and outcome of axial spondyloarthritis. In: Mease P and Khan MA (Eds.). Axial Spondyloarthritis. Elsevier, 2018 (in press).

48.        Akkoc N, Khan MA. Epidemiology of axial spondyloarthritis. In: Mease P and Khan MA (Eds.), Axial Spondyloarthritis. Elsevier, 2019 (in press).

49.        Caballero-Uribe CV and Khan MA. Patient Education and Patient Service Organsations. In: Mease P and Khan MA (Eds.), Axial Spondyloarthritis. Elsevier, 2019 (in press).

50.        Mease P, Khan MA. Introduction. In: Mease P and Khan MA (Eds.). Axial Spondyloarthritis. Elsevier, 2019 (in press).

SCIENTIFIC ARTICLES:

1.         Ballou SP, Khan MA, Kushner I: Diffuse intervertebral disc calcification in primary amyloidosis.                          Ann Intern Med 85: 616‑617, 1976.

2.         Khan MA, Kushner I, Braun WE: Comparison of clinical features of HLA‑B27 positive and negative patients with ankylosing spondylitis. Arthritis Rheum 20: 909‑912, 1977.

3.         Khan MA, Braun WE, Kushner I, Grecek DE, Muir WA, Steinberg AG: HLA‑B27 in ankylosing spondylitis: Differences in frequency and relative risk in American Blacks and Caucasians. J Rheumatol 4(Suppl. 3): 39‑43, 1977.

4.         Khan MA, Kushner I:  Improvement of rheumatoid arthritis following splenectomy for Felty syndrome. JAMA 237: 1116‑1118, 1977.

5.         Ballou SP, Khan MA, Kushner I, Harris JW:  Secondary gout in hemoglobinopathies: Report of two cases and review of the literature.  Am J Hematol 2: 397‑402, 1977.

6.         Khan MA:  HLA‑B27 antigen and rheumatic diseases.  Ohio State Med J 73: 619‑621, 1977.

7.         Khan MA:  HLA and disease.  JIMA 8: 15‑17, 1977.

8.         Flatuauer FE, Khan MA:  Septic arthritis caused by Enterobacter agglomerans. Arch Intern Med 138: 788, 1978.

9.         Ballou SP, Khan MA, Kushner I:  Giant cell arteritis in a Black patient. Ann Intern Med 88: 659‑660, 1978.

10.     Khan MA, Kushner I, Braun WE:  A subgroup of ankylosing spondylitis associated with HLA‑B7 in American Blacks.  Arthritis Rheum 21: 528‑530, 1978.

11.     Khan MA, Kushner I, Braun WE, Zachary AA, Steinberg AG:  HLA‑B27 homozygosity in ankylosing spondylitis: relationship to risk and severity.  Tissue Antigens 11: 434- 438, 1978.

12.     Lam M, Ricanati ES, Khan MA, Kushner I:  Reversal of severe renal failure in systemic sclerosis.                          Ann Intern Med 89: 642‑643, 1978.

13.     Khan MA: Chondrocalcinosis articularis (pseudogout): A study of 72 patients. JIMA 9: 9‑10, 1978.

14.     Dejelo CL, Braun WE, Khan MA, Clough JD:  HLA‑DR antigens and ankylosing spondylitis.                 Transplantation Proceedings 10: 971‑972, 1978.

15.     Khan MA:  Race‑related differences in HLA association with ankylosing spondylitis and Reiter's disease in American Blacks and Whites.  J Natl Med Assoc 70: 41‑42, 1978.

16.     Khan MA, Askari AD, Braun WE, Aponte CJ: Low association of HLA‑B27 with Reiter's syndrome in Blacks. Ann Intern Med 90: 202‑203, 1979.

17.     Khan MA: Laboratory tests useful in rheumatological evaluation.  JIMA 1 & 2: 5‑9, 1979.

18.     Khan MA, Kushner I, Freehafer AA: Sacroiliac joint abnormalities in paraplegics.                                                   Ann Rheum Dis 38: 317‑319, 1979.

19.     Khan MA, Kushner I:  Ankylosing spondylitis and multiple sclerosis: A possible association.                          Arthritis Rheum. 22: 784‑786, 1979.

20.     Khan MA: Recent advances in knowledge concerning genetic factors which predispose to rheumatic diseases.  JIMA. 10:(No. 3 & 4): 4‑5,1979.

21.     Khan MA: Clinical application of HLA‑B27 test in rheumatic diseases: A current perspective.                               Arch Intern Med 140: 177‑180, 1980.

22.     Schoenberg LM, Kushner I, Khan MA: Concanavalin‑A induced transformation of mononuclear cells: Influence of plasma from patients receiving anti‑inflammatory agents.  Proc Soc Exp Biol Med 164: 192‑195, 1980.

23.     Khan MA, Kushner I, Braun WE: Genetic heterogeneity in primary ankylosing spondylitis.          J Rheumatol.  7: 383‑386, 1980.

24.     Khan MA, Khan MK, Kushner I: Survival among patients with ankylosing spondylitis: A life‑table analysis.  J Rheumatol 8: 86‑90, 1981.

25.     Khan MA, Kushner I, Braun WE: Association of HLA‑A2 with uveitis in HLA‑B27 positive patients with ankylosing spondylitis.  J Rheumatol 8: 295‑298, 1981.

26.     Khan MA, Kushner I, Braun WE, Dejelo CL, Ballou SP: Clinical and HLA studies in multiple case families with rheumatoid arthritis. Tissue Antigens 18:136‑138,1981.

27.     Khan MA, Ballou SP: Tendon rupture in systemic lupus erythematosus. J Rheumatol 8: 308‑310, 1981.

28.     Ballou SP, Khan MA, Kushner I: Clinical features of systemic lupus erythematosus. Differences related to race and age of onset.  Arthritis Rheum 25: 55‑60, 1982.

29.     Khan MA, Khan MK:  Diagnostic value of HLA‑B27 testing in ankylosing spondylitis and Reiter's syndrome.  Ann Intern Med 96: 70‑76, 1982.

30.     Thompson GH, Khan MA, Bilenker RM: Spontaneous atlantoaxial subluxation as a presenting manifestation of juvenile ankylosing spondylitis.  Spine 7: 78‑79, 1982.

31.     Hammoudeh M, Khan MA: Cranial arteritis as the initial manifestation of malignant histiocytosis.  J Rheumatol   9: 443‑447, 1982.

32.     Khan MA: Axial arthropathy in Whipple's disease.  J Rheumatol 9: 928‑929, 1982.

33.     Yagan R, Khan MA, Bellon EM: Spondylitis and posterior longitudinal ligament ossification in the cervical spine.  Arthritis Rheum. 26: 226‑230, 1983.

34.     Khan MA, Kammer G, Dejelo CL, Kushner I, Braun WE, Ballou SP: Study of HLA antigens in familial and sporadic rheumatoid arthritis. Tissue Antigens 21: 35‑38, 1983.

35.     Hammoudeh M, Khan MA: Genetics of HLA associated diseases: Ankylosing spondylitis.           J Rheumatol. 10: 301‑304, 1983.

36.     Klein SM, Khan MA: Hepatitis, toxic epidermal necrolysis, and pancreatitis in association with sulindac therapy.  J Rheumatol. 10: 512‑513, 1983.

37.     Khan MA, Kushner I, Weitkamp LR: Genetics of HLA‑associated disease; rheumatoid arthritis.                         Tissue Antigens 22: 182‑185, 1983.

38.     Jumshyd A, Khan MA:  Ankylosing hyperostosis in American Blacks: A longitudinal study. Clin Rheumatol 2: 123‑126, 1983.

39.     Yagan R, Khan MA:  Confusion of roentgenographic differential diagnosis between ankylosing hyperostosis (Forestier's disease) and ankylosing spondylitis. Clin Rheumatol. 2: 285‑292, 1983.

40.     Khan MA: B7‑CREG and ankylosing spondylitis. Br J Rheumatol. 22 (Supplement 2): 129‑132, 1983.

41.     Miron SD, Khan MA, Wiesen E, Kushner I, Bellon EM:  The value of quantitative sacroiliac scintigraphy in detection of sacroiliitis. Clin Rheumatol. 2: 407‑414, 1983.

42.     Mehra NK, Khan MA, Vaidya MC, Malaviya AN, Batta RK:  HLA antigens in acute anterior uveitis and spondyloarthropathies in Asian Indians and their comparison with American Whites and Blacks. J Rheumatol. 10: 981‑984, 1983.

43.     Raum D, Awdeh Z, Glass D, Kammer G, Khan MA, Coblyn JS, Weinblatt M, Holdsworth D, Strong L, Rossen RD, Brewer E, Yunis E, Alper CA: Extended haplotypes of chromosome 6 in adult rheumatoid arthritis.  Arthritis Rheum. 27: 516‑521, 1984.

44.     Khan MA, Khan MK: HLA‑B27 testing in the diagnosis of spondylitic diseases. Intern Med Specialist. 5: 55‑65, 1984.

45.     Khan MA: Temporal arteritis and polymyalgia rheumatica.  Signs of giant cell arteritis. Pak J Ophthalmol. 1: 33‑36, 1984.

46.     van der Linden SM, Khan MA: The risk of ankylosing spondyltis in HLA‑B27 positive individuals: A reappraisal. (Editorial) J Rheumatol. 11: 727‑728, 1984.

47.     Khan MA, van der Linden SM, Kushner I, Valkenburg HA, Cats A:  Spondylitic disease without radiological evidence of sacroiliitis in relatives of HLA‑B27 positive patients.  Arthritis Rheum 28: 40‑43, 1985.

48.     Khan MK, Khan MA: Selection of optimal dose.  Computers & Biomedical Research 18: 193‑203, 1985.

49.     Khan MA: Diclofenac in the treatment of ankylosing spondylitis:  Review of worldwide clinical experience and report of a double‑blind comparison with indomethacin. Semin Arthritis Rheum 15(Supplement 1): 80‑84, 1985.

50.     Ballou SP, Khan MA, Kushner I: Intravenous pulse methylprednisolone followed by alternate‑day corticosteroid therapy in lupus erythematosus: A prospective evaluation.                   J Rheumatol 12: 944‑948, 1985.

51.     de Vries RRP, Nijenhuis LE, Khan MA, Mehra NK:  Paradoxical inheritance of HLA‑linked susceptibility to rheumatoid arthritis.  Tissue Antigens 26: 286‑292, 1985.

52.     van der Linden S, Khan MA:  Iliosakralarthritis und spondylitis anklyosans Bechterew: Früherfassung und therapie.  Therapeutische Umschau 42: 707‑710, 1985.

53.     Arnett FC Jr, Khan MA, Wilkens RF:  Are you missing ankylosing spondylitis? (E. Fuller, ed).  Patient Care 20: 51‑78, January 30, 1986.

54.     Payami H, Thomson G, Khan MA, Grennan DM, Sanders P, Dyer P, Dostal C:  Genetics of rheumatoid arthritis.  Tissue Antigens 27: 57‑63, 1986.

55.     Khan MA, Khan MK: Analysis of genetic susceptibility to familial rheumatoid arthritis.                                    Disease Markers 4: 77‑85, 1986.

56.     Khan MA, Khan MK:  HLA studies in familial and sporadic rheumatoid arthritis. Disease Markers 4: 67‑76, 1986.

57.     Yamashita TS, Khan MA, Kushner I:  Genetic analysis of families with multiple cases of rheumatoid arthritis.  Disease Markers 4: 113‑121, 1986.

58.     Shah BC, Khan MA:  Review of ankylosing spondylitis.  Comprehensive Therapy 13(Supplement 3): 52‑59, 1987.

59.     Khan MA:  A double blind comparison of dicloflenac and indomethacin in the treatment of ankylosing spondylitis.    J Rheumatol 14: 118‑123, 1987.

60.     Cats A, van der Linden SM , Goei The HS, Khan MA:  Proposals for diagnostic criteria of ankylosing spondylitis and allied disorders. Clin Exp Rheumatol  5: 167‑171, 1987.

61.     Payami H, Khan MA, Grennan DM, Sanders PA, Dyer PA, Thomson G:  Analysis of genetic interrelationship among HLA‑associated diseases. Am J Hum Genet 41: 331‑349, 1987.

62.     Yagan R, Radivoyevitch M, Khan MA:  Double cortical line in the acetabular roof: A sign of disuse osteoporosis.  Radiology 165: 171‑175, 1987.

63.     van der Linden SM, Goei The HS, Khan MA, Cats A, Valkenburg HA:  Roma locata, causa non finita:  Parameters that need to be considered in revision of criteria for ankylosing spondylitis and seronegative polyarthritis.  Clin Exp Rheumatol  5(Supplement 1): S109‑S110, 1987.

64.     Khan MA, Wolfe F, Kleinheksel SM, Molta C:  HLA DR4 and B27 antigens in familial and sporadic rheumatoid arthritis.  Scand J Rheumatol 16: 433‑436, 1987.

65.     Khan MA:  Immunogenetics of ankylosing spondylitis: Clinically oriented aspects. Clin Exp Rheumatol 5(Supplement 1): S49‑S52, 1987.

66.     Yagan R, Khan MA, Marmolya G:  Role of abdominal CT, when available in patients' records, in the evaluation of degenerative changes of the sacroiliac joints.  Spine 12: 1046‑1051, 1987.

67.     Khan MK, Khan MA:  Uniformly most powerful tests for non‑random segregation.  Technical Reports No. DMS‑MK 12‑86.  Department of Mathematical Sciences, Kent State University, Kent, Ohio.

68.     Wolfe F, Kleinheksel SM, Khan MA:  Familial versus sporadic rheumatoid arthritis: A comparison of the demographic and clinical characteristics of 956 patients. J Rheumatol 15: 400‑404, 1988.

69.     Pazirandeh M, Ziran BH, Khandelwal BK, Reynolds TL, Khan MA:  Relapsing polychondritis and spondyloarthropathies.  J Rheumatol 15: 630‑632, 1988.

70.     van der Linden SM, Khan MA, Rentsch H‑U, Gerber N, Cats A, Valkenburg HA, Tugwell PX:  Chest pain without radiographic sacroiliitis in relatives of patients with ankylosing spondylitis.     J Rheumatol 15: 836‑839, 1988.

71.     Khan MA, Yamashita TS, Reynolds TL, Wolfe F, Khan MK:  HLA‑DR4 genotype frequency and gender effect in familial rheumatoid arthritis.  Tissue Antigens 31: 254‑258, 1988.

72.     Khan MA:  Genetics of HLA‑B27.  Br J Rheumatol 27(Supplement II): 6‑11, 1988.

73.     Wolfe F, Kleinheksel SM, Khan MA:  Prevalence of familial occurrence in patients with rheumatoid arthritis.  Br J Rheumatol 27(Supplement II): 150‑152, 1988.

74.     Stastny P, Ball EJ, Khan MA, Olsen NJ, Pincus T, Gao X:  HLA‑DR4 and other genetic markers in rheumatoid arthritis.  Br J Rheumatol 27(Supplement II): 132‑138, 1988.

75.     Khan MA, Arnett FC Jr., Moskowitz RW:  HLA‑B27: Is it really of diagnostic help? Articulations 5(No. 1): 3‑6, 1988.

76.     Khan MA:  Ankylosing spondylitis and heterogeneity of HLA‑B27. Semin Arthritis Rheum 18: 134‑141, 1988.

77.     Gao X, Ball EJ, Dombrausky L, Olsen NJ, Pincus T, Khan MA, Wolfe F, Stastny P:  Class II human leukocyte antigen genes and T cell receptor polymorphisms in patients with rheumatoid arthritis. Am J Med 85(Supplement 6A):14‑16, 1988.

78.     Schwartz BD, Arnett FC, Khan MA, Nepom GT, Shulman LE. Suggestions for future research directions resulting from this workshop. Am J Med 85(Supplement 6A):61, 1988.

79.     Mackiewicz A, Khan MA, Reynolds TL, van der Linden S, Kushner I:  Serum IgA and acute phase proteins in ankylosing spondylitis.  Ann Rheum Dis 48: 99‑103, 1989.

80.     Khan MA, Abdul‑Karim A:  Interaction between HLA antigens and bacteria. Rev Mex Reumat 4(Supplement 1): 14‑16, 1989.

81.     Khan MA, Abdul‑Karim A:  Diagnosis of ankylosing spondylitis.  Rev Mex Reumat 4(Supplement 1): 26‑28, 1989.

82.     Molta CT, Khan MA, Aponte JC, Reynolds TL, Macintyre SS:  Familial occurrence of systemic sclerosis, rheumatoid arthritis and other immunological disorders:  Report of two kindreds with study of HLA antigens and review of the literature. Clin Exp Rheumatol 7: 229‑236, 1989.

83.     Khan MA:  Editorial Comment:  HLA‑B27 testing in ankylosing spondylitis:  An analysis of the pretesting assumptions.  J Rheumatol 16: 634‑636, 1989.

83.       Zanetakis E, Khan MA, Yagan R, Kushner I:  Ochronotic arthropathy, spinal pseudoarthrosis and HLA‑B27.  J Orthopedic Rheumatol 2: 48‑53, 1989.

84.       Robinson WP, van der Linden SM, Khan MA, Rentsch H‑U, Cats A, Russell AS, Thomson G:  HLA‑Bw60 increases susceptibility to ankylosing spondylitis in HLA‑B27 positive individuals.  Arthritis Rheum 32: 1135‑1141, 1989.

85.       Whitman GJ, Khan MA:  Unusual occurrence of ankylosing spondylitis and multiple sclerosis in a black patient.  Cleve Clin J Med 56: 819‑822, 1989.

86.       Khan MA:  A brief review of the HLA system.  JPMA 39: 187‑191, 1989.

87.       Arnett FC, Khan MA, Willkens RF:  A new look at ankylosing spondylitis. Patient Care 23: 82‑101, 1989.

88.       Khan MA, Yue CC:  Molecular basis for the HLA association of rheumatic diseases.  Autoimmunity Forum Rheumatol 1(No. 3): 2‑4, 1989.

89.       Khan MA:  Newer clinical and radiographic manifestations of the seronegative spondyloarthropathies.  Curr Opin Rheumatol 1: 139‑143, 1989.

90.       Khan MA, van der Linden SM:  A wider spectrum of spondyloarthropathies. Semin Arthritis Rheum 20: 107‑113, 1990.

91.       Khan MA, van der Linden SM: Ankylosing spondylitis and associated diseases. Rheum Dis Clin N Am 16: 551‑579, 1990.

92.       Khan MA, van der Linden SM:  Ankylosing spondylitis: Clinical aspects. Spine:  State of the Art Reviews 4: 529‑551, 1990.

93.       Yagan R, Khan MA:  Confusion of roentgenographic differential diagnosis of ankylosing hyperostosis (Forestier's disease) and ankylosing spondylitis. Spine:  State of the Art Reviews 4:561‑575, 1990.

94.       Khan MA:  An overview of the HLA system.  Spine:  State of the Art Reviews 4:595‑605, 1990.

95.       Khan MA, Khan MK:  HLA‑B27 as an aid to diagnosis of ankylosing spondylitis. Spine:  State of the Art Reviews 4: 617‑625, 1990.

96.       Khan, MA, van der Linden SM:  Undifferentiated spondyloarthropathies. Spine:  State of the Art Reviews 4: 657‑664, 1990.

97.       Turakhia AK, Khan MA:  Splinter hemorrhage as a clinical manifestation of cholesterol embolization.  J Rheumatol 17: 1083‑1086, 1990.

98.       Khan MA:  Medical and surgical treatment of spondyloarthropathies. Curr Opin Rheumatol 2:592‑599, 1990.

99.       Khan MA:  Early diagnosis of ankylosing spondylitis. Revista Medica del Hospital General 53:119‑123, 1990.

100.   Reynolds TL, Khan MA, van der Linden S, Cleveland RP:  Differences in HLA‑B27 positive and negative patients with ankylosing spondylitis: Study of clinical disease activity and levels of serum IgA, C‑reactive protein, and haptoglobin. Ann Rheum Dis 50: 154‑157, 1991.

101.   Rigby AS, Silman AJ, Voelm L, Gregory JC, Ollier WER, Khan MA, Nepom GT, Thomson G:  Investigating the HLA components in rheumatoid arthritis: An additive (dominant) mode of inheritance is rejected, a recessive mode is preferred. Genet Epidemiol 8: 153‑175, 1991.

102.   Khan MA:  An overview of clinical spectrum and heterogeneity of spondyloarthropathies. Rheum Dis Clin N Am 18: 1‑10, 1992.

103.   Zeidler H, Mau W, Khan MA:  Unidifferentiated spondyloarthropathies. Rheum Dis Clin N Am 18: 187‑202, 1992.

104.   Olafsson S, Khan MA:  Musculoskeletal features of acne, hidradenitis suppurativa and dissecting cellulitis of the scalp. Rheum Dis Clin N Am 18: 215‑224, 1992.

105.   Khan MA, Kellner H:  Immunogenetics of spondyloarthropathies. Rheum Dis Clin N Am 18:837‑864, 1992.

106.   Sun JP, Khan MA, Farhat AZ, Bahler RC:  Alterations in cardiac diastolic function in patients with ankylosing spondylitis.  Intl J Cardiol 37: 65‑72, 1992.

107.   Khan MA:  HLA‑B27 and pathogenesis of ankylosing spondylitis.  Reumatizam (Supplement) 99‑103, 1992.

108.   Khan MA:  Spondyloarthropathies:  editorial overview.  Curr Opin Rheumatol 5: 405-407, 1993.

109.   Khan MA, Lai J‑H, Chou C‑T, Chang D‑M, Liu H‑C:  Spinal fractures in ankylosing spondylitis. J Musculoskeletal Med 10: 45‑57, 1993.

110.   Khan MA:  Etiopathogenesis of ankylosing spondylitis.  Rheumatol Rev 2: 67-71, 1993.

111.   Khan MA:  Risk factors for rheumatic diseases.  Revista Espinola de Rheumatologia 20(Supplement 1): 57-58, 1993.

112.   Khan MA:  Genetics. Revista Espinola de Rheumatologia 20(Supplement 1): 170-171, 1993.

113.   Khan MA:  Influence of genetic factors on the heterogeneity of the spectrum of spondyloarthropathies. Revista Espinola de Rheumatologia 20(Supplement 1): 271, 1993.

114.   Khan MA: Pathogenesis of ankylosing spondylitis: recent advances. (Editorial).  J Rheumatol 20:1273-1277, 1993.

115.   Toivanen A, Khan MA:  Therapeutic dilemmas in ankylosing spondylitis and related spondyloarthropathies.  Rheumatol Rev 3: 21-27, 1994.

116.   Kahn M‑F, Khan MA:  SAPHO Syndrome.  Balliere's Clinical Rheumatology 8:333-362, 1994.

117.   Khan MA:  Spondyloarthropathies: editorial overview. Curr Opin Rheumatol 6:351-353, 1994.

118.   Mackiewicz A, Khan MA, Gorny A, Kapcinska M, Calabrese LH, Espinoza LR:  Glycoforms of α1-acid glycoprotein in sera of human immunodeficiency virus infected individuals.  J Infect Dis 169:1360-1363, 1994.

119.   McDermott M, Kastner DL, Holloman J, Schmidt-Wolf G, Lundberg A, Sinha A, Amos C, Khan MA, Wolfe F, Rubin L, Mulcahy B, Cashin P, Molloy MGM, Clegg R, Ward R, McDevitt HO. The Role of T-Cell Receptor β Chain Genes in the Susceptibility to Rheumatoid Arthritis. Annals of the New York Academy of Sciences, 1995; 756: 173–5. doi: 10.1111/j.1749-6632.1995.tb44502.x

120.   McDermott M, Kastner DL, ..., Khan MA, et al:  The role of T cell receptor ß chain genes in susceptibility to rheumatoid arthritis. Arthritis Rheum 1995; 38:91-5.

121.   Amor B, Dougados M, Khan MA:  Management of refractory ankylosing spondylitis and related spondylarthropathies. Rheum Dis Clin N Am 1995; 21:117-28.

122.   Khan MA:  HLA-B27 and its subtypes in world populations. Curr Opin Rheumatol 1995; 7:263-9.

123.   Khan MA:  Arthritis and autoimmunity:  Report on the 15th Sigrid Juselius Symposium. Rheumatol Int 1995; 15:39-42.

124.   Feltkamp TE, Khan MA, Lopez de Castro JA.  The pathogenic role of HLA-B27. Immunology Today 1996; 17:5-7.

125.   Khan MA: Epidemiology of HLA-B27 and arthritis. Clin Rheumatol 1996; 15(suppl.1):10-12.

126.   Mustafa K, Khan MA: Recognising and managing reactive arthritis. J Musculoskeletal Med 1996; 13(#6):28-41.

127.   Khan MA: Editorial review: Spondyloarthropathies / spondyloarthritides. Curr Opin Rheumatol 1996; 8:267-8.

128.   Ahmed Q, Chung-Park M, Mustafa K, Khan MA. Psoriatic spondyloarthropathy with secondary amyloidosis.  J Rheumatol 1996; 23:1107-10.

129.   McDermott E, Khan MA, ARC UK National Repository, Deighton C. Further evidence for genetic anticipation in familial rheumatoid arthritis. Ann Rheum Dis 1996; 55: 475-7.

130.   Khan MA: Spondyloarthropathies: Editorial review. Curr Opin Rheumatol 1997; 9:281-3.

131.   van der Heijde D, Bellamy N, Calin A, Dougados M, Khan MA, van der Linden S. Preliminary core sets for endpoints in ankylosing spondylitis. J Rheumatol 1997; 24: 2225-9.

132.   Khan MA: Slow-acting anti-rheumatic drugs in severe ankylosing spondylitis [Editorial]. J Clin Rheumatol 1998; 4(3): 109-11.

133.   Khan MA: Spondyloarthropathies: Editorial overview. Curr Opin Rheumatol 1998; 10: 279-81.

134.   Walsh B, Yocum D, Khan MA: Arthritis and HLA-B27 in North American tribes. Curr Opin Rheumatol 1998; 10: 319-25.

135.   Dougados M, Revel M, Khan MA: Spondylarthropathy treatment: Progress in medical treatment, physical therapy and rehabilitation. Balliere's Clinical Rheumatology 1998; 12: 717-36.

136.   Espinoza L, Khan MA: Recognizing the spondyloarthropathies. Patient Care 1999; 33(#7):183-4.

137.   Khan MA: A current perspective on ankylosing spondylitis and related spondyloarthropathies. JIRA 1999; 7:16-22.

138.   Khan MA: Disease assessment in ankylosing spondylitis JIRA 1999; 7:52-4.

139.   Khan MA: Management of ankylosing spondylitis and related spondyloarthropathies. JIRA 1999; 7:87-92.

140.   van der Heijde DMFM, van der Linden SM, Bellamy N, Calin A, Dougados M, Khan MA. Which domains should be included in a core set for endpoints in ankylosing spondylitis? Introduction to the ankylosing spondylitis module of OMERACT IV. J Rheumatol 1999; 26:945-7.

141.   van der Heijde DMFM, Calin A, Dougados M, Khan MA, van der Linden SM, Bellamy N, on behalf of the ASAS working group. Selection of specific instuments for each domain in core set for DC-ART, SM-ARD, physical therapy, and clinical record keeping in ankylosing spondylitis: Progress report of ASAS working group. J Rheumatol 1999; 26:951-4.

142.   Khan MA: Spondyloarthropathies: Editorial overview. Curr Opin Rheumatol 1999; 11:233-4.

143.   McGonagle D, Khan MA, Marzo-Ortega H, O’Connor P, Gibbon W, Emery P: Enthesitis in ankylosing spondylitis and related spondyloarthropathies. Curr Opin Rheumatol1999; 11: 244-50.

144.   Yunus MB, Khan MA, Rawling KK, Green JR, Shah S. A genetic study of multicase families with fibromyalgia syndrome by HLA linkage analysis. J Rheumatol 1999; 26: 408-12.

144.  Khan MA: Patient-doctor. Ann Intern Med 2000, 133: 233-5.

145.  Khan MA: HLA-B27 polymorphism and association with disease [Editorial]. J Rheumatol 2000; 27: 1110-4.

146.  Braun J, Khan MA, Sieper J. Entheses and enthesopathy: What is the target of the immune response? Ann Rheum Dis 2000, 59: 985-994.

147.  Khan MA: Update: the twenty subtypes of HLA-B27. Curr Opin Rheumatol 2000, 12: 235-238.

148.  Feldtkeller E, Bruckel J, Khan MA. Scientific contributions of the ankylosing spondylitis patient advocacy groups. Curr Opin Rheumatol 2000, 12: 239-247.

149.  Mijiyawa M, Oniankitan O, Khan MA. Spondyloarthropathies in sub-Saharan Africa. Curr Opin Rheumatol 2000, 12:281-286.

150.  Khan MA: My self-portrait. Clin Rheumatol 2001, 20:1-2.

151.  François RJ, Braun J, Khan MA: Entheses and enthesitis: a histopathological review and relevance to spondyloarthropathies. Curr Opin Rheumatol 2001, 13:255-264.

152.  Reveille JD, Ball EJ, Khan MA: HLA-B27 and genetic predisposing factors in spon­dy­loarthropathies. Curr Opin Rheumatol 2001, 13:265-272.

153.  Ball EJ, Khan MA: HLA-B27 polymorphism. Bone Joint Spine 2001, 68:378-382.

154.  Granfors K, Märker-Hermann E, De Keyser P, Khan MA, Veys EM, Yu DT. The cutting edge of spondyloarthropathy research in the millennium. Arthritis Rheum 2002, 46:606-613.

155.  Khan MA. Update on spondyloarthropathies. Ann Intern Med 2002, 136:896-907.

156.  Khan MA, Ball EJ: Genetic aspects of ankylosing spondylitis. Best Pract Res Clin Rheumatol 2002; 16:675-690.

157.  Khan MA. HLA-B27 and spondyloarthropathies [Editorial]. Revista Espanola de Rheumatologia 28:405-407, 2002.

158.  Khan MA. Introductory comments. New treatment strategies in ankylosing spondylitis. Ann Rheum Dis 2002; 61 (Suppl 3): iii3-7.

159.  Braun J, van der Heijde D, Dougados M, Emery P, Khan MA, Sieper J, van der Linden S. Staging of patients with ankylosing spondylitis: A preliminary proposal. Ann Rheum Dis 2002; 61 (Suppl 3): iii19-23.

160.  Dougados M, Dijkmanns B, Khan MA, Maksymowych W, van der Linden S, Brandt J. Conventional treatments for ankylosing spondylitis. Ann Rheum Dis 2002; 61 (Suppl 3): iii40-50.

161.  Khan MA. Ankylosing Spondylitis – The history of medical therapies. Clin Exp Rheumatol 2002; 20(Suppl 28): S3-S5.

162.  Khan MA. Thoughts concerning the early diagnosis of ankylosing spondylitis and related diseases. Clin Exp Rheumatol 2002; 20(Suppl 28): S6-S10.

163.  Feldtkeller E, Khan MA, van der Linden S, van der Heijde D, Braun J: Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with an­ky­los­ing spon­dy­litis. Rheumatol Int 2003; 23:61-66.

164.  Pham T, van der Heijde D, Calin A, Khan MA, van der Linden S, Bellamy N, Dougados M. Initiation of biologics in ankylosing spondylitis patients: Results of a Delphi technique within the ASAS group. Ann Rheum Dis 2003; 62: 812- 816.

165.  Rudwaleit M, van der Heijde D, Khan MA, Braun J, Sieper J. How to diagnose axial spondyloarthropathy early? Ann Rheum Dis 2004; 63:535-43.

166.  Zhang G, Luo J, Bruckel J, Weisman  M, Schumacher HR, Khan MA, et al. Genetic Studies in Familial Ankylosing Spondylitis Susceptibility Arthritis Rheum 2004; 50:2246-2254.

167.  Jin L , Weisman M, Zhang, G, Ward, M, Akey, JM, Bruckel J, Inman R, Luo J, Khan MA, et al. Lack of Linkage of IL1RN Genotype with Ankylosing Spondylitis Susceptibility. Arthritis Rheum 2004; 50:3047-3048

168.  Jin L , Weisman M, Zhang, G, Ward, M, Luo J, Bruckel J, Inman R, Khan MA, et al. Lack of Association of MMP3 with Ankylosing Spondylitis Susceptibility and Severity. Rheumatol 2005; 44:55-60.

169.  Martin TM, Zhang G, Luo J, Jin L, Doyle TM, Rajska BM, ----- Khan MA, -----, Rosenbaum JT, Reveille J. A locus on chromosome 9p predisposes to a specific disease manifestation, acute anterior uveitis, in ankylosing spondylitis, a genetically complex, multisystem, inflammatory disease. Arthritis Rheum 2005; 52:269-274.

170.  Rudwaleit M, Khan MA, Sieper J. The challenge of diagnosis and classification in early ankylosing spondylitis: Do we need new criteria? Arthritis Rheum. 2005; 52:1000-1008.

171.  Khan MA. The perspective of two paintings by a patient-physician. Journal of Medicine and the Person. 2005; 3(No:2): 83-84.

172.  Akkoc N, Khan MA. Etiopathogenic role of HLA-B27 alleles in ankylosing spondylitis. APLAR J Rheumatol   2005; 8: 146-153.

173.  Zochling J, van der Heijde D, Burgos-Vargas R, Collantes E, Davis J, Dijkmans B, Dougados M, Géher P, Inman R, Khan MA, et al. ASAS / EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis. 2006; 65:442-452.

174.  Sieper J, Rudwaleit M, Khan MA, Braun J. Concepts and epidemiology of spondyloarthritis.
Best Pract Res Clin Rheumatol. 2006 June; 20(3):401-17.

175.  Akkoc N, van der Linden S, Khan MA. Ankylosing spondylitis and symptom-modifying vs disease-modifying therapy. Best Pract Res Clin Rheumatol. 2006 June; 20(3):539-57.

176.  Elyan M, Khan MA. The role of non-steroidal anti-inflammatory medications and exercise in the treatment of ankylosing spondylitis. Curr Rheumatol Report 2006; 8: 255-259.

177.  Khan MA, Akkoc N. Commentary: Ten key recommendations for the management of ankylosing spondylitis.  Nature Clin Pract Rheumatol 2006; 2(9):468-9.

178.  Khan MA. Ankylosing spondylitis: A dual perspective of the current issues and challenges. J Rheumatol Suppl 2006; Sep;78:1-3.

179.  Elyan M, Khan MA. Diagnosing ankylosing spondylitis. J Rheumatol Suppl 2006; Sep;78:12-23.

180.  Khan MA, Mathieu A, Sorrentino R, Akkoc N. The pathogenic role of HLA-B27 and its subtypes in ankylosing spondylitis.   Autoimmunity Reviews 2007; 6(3):183-9.

181.  Khan MA, Clegg DO, Deodhar AA, et al. Meeting Report. 2006 Annual Research and Education Meeting of the Spondyloarthritis Research and Therapy Network (SPARTAN). J Rheumatol 2007; 34(5):1118-1124.

182.  Weber U, Pfirrmann CWA, Khan MA. Ankylosing spondylitis: update on imaging and therapy. Intl J Adv Rheumatol. 2007; 5: 2-7.

183.  Gladman DD, Inman RD, Cook RR, -- Khan MA, -- Maksymowych WP. International Spondyloarthritis Inter-observer Reliability Exercise – The INSPIRE Study: I. Assessment of Spinal Measures. J Rheumatol 2007; 4(8):1733-9.

184.  Gladman DD, Inman RD, Cook RR, -- Khan MA, -- van der Heijde, D. International Spondyloarthritis Inter-observer Reliability Exercise – The  INSPIRE Study: II. Assessment of peripheral joints, enthesitis and dactylitis. J Rheumatol 2007; 34(8):1740-5

185.  Elyan M, Khan MA. Clinical trials report: Is low-dose Infliximab every 8 Weeks Effective in treating ankylosing spondylitis? Curr Rheumatol Report 2007; 9(5):351-2.

186.  Elyan M, Khan MA. Clinical trials report: Another look at low-dose Infliximab in treating ankylosing spondylitis. Curr Rheumatol Report 2007; 9(5):352.  

187.  Elyan M, Khan MA. Clinical trials report: Sulfasalazine in undifferentiated spondyloarthropathies. Curr Rheumatol Report 2007; 9(5):349-50.  

188.  Olivieri I, D’Angelo S, Cutro MS, Padula A, Peruz G, Montaruli M, Scarano E, Giasi V, Palazzi P, Khan MA. Diffuse Idiopathic Skeletal Hyperostosis may give the typical postural abnormalities of advanced ankylosing spondylitis. Rheumatology (Oxford). 2007; 46(11):1709-11.

189.  Elyan M, Khan MA. Update on spondyloarthritis. J Musculoskeletal Med 2008; January, p. 31-40.

190.  Khan MA. HLA-B27 and its pathogenic role. J Clin Rheumatol 2008; 14(1):50-2.

191.  Elyan M, Khan MA. Spondyloarthropathies: Update on Diagnosis and Therapy. Consultant  2008; August, p. 681-91.

192.  Onen, F, Akar S, Birlik M, Sari I, Gurler O, Ergor Alp, Manisali M, Khan MA, Akkoc N. Prevalence of ankylosing spondylitis and related spondyloarthritis in an urban area of Izmir, Turkey.  J Rheumatol. 2008; 35(2):305-9.

193.  Elyan M, Khan MA. Does physical therapy have a place in the treatment of ankylosing spondylitis. Curr Opin Rheumatol. 2008; 20(3):282-6.

194.  Colbert RA, Deodhar AA, Khan MA, et al. 2007 Annual Research and Education Meeting of the Spondyloarthritis Research and Therapy Network (SPARTAN). J Rheumatol. 2008; 35:1398-02.

195.  Weber U, Pfirrmann CWA, Kissling RO, MacKenzie CR, Khan MA. Early spondyloarthritis in HLA-B27 positive monozygotic twin pair: A highly concordant onset, sites of involvement, and disease course. J Rheumatol. 2008; 35(7):1464-7.

196.  James N, Elyan M, Khan MA. Clinical trials report: Is continuous treatment with infliximab superior to treatment upon symptom relapse in ankylosing spondylitis? Curr Rheumatol Report. 2008; 10:347-8.

197.  Khan MA. Recent advances in the genetics of ankylosing spondylitis. Future Rheumatol. 2008; 3(5): 403-5.

198.  Rudwaleit M, Landewé R, van der Heijde D, Listing J, Brandt J, ...., Khan MA, ...., Sieper J. The development of Assessment in SpondyloArthritis International Society (ASAS) classification criteria for axial spondyloarthritis (Part I): Classification of paper patients by expert opinion including uncertainty appraisal. Ann Rheum Dis. 2009; 68(6):770-6. 

199.  Rudwaleit M, van der Heijde D, Landewé R, Listing J, Akkoc N, ….,  Khan MA, …., Sieper J. The development of Assessment in SpondyloArthritis International Society (ASAS) classification criteria for axial spondyloarthritis (Part II): Validation and final selection. Ann Rheum Dis. 2009; 68(6):777-83.

200.  Sieper J , van der Heijde D, Landewé R, Brandt J, Burgos-Vargas R, Collantes-Estevez E, Dijkmans B, Dougados M, Khan MA, …., Rudwaleit M. New criteria for inflammatory back pain in patients with chronic back pain – a real patient exercise of the Assessment in SpondyloArthritis International Society (ASAS). Ann Rheum Dis. 2009 68(6):784-8.

201.  Weber U, Maksymowych WP, Jurik AG,  Pfirrmann CWA, Rufibach K, Kissling RO, Khan MA, Lambert RGW,Hodler J. Validation of whole body against conventional magnetic resonance imaging for scoring acute inflammatory lesions in the sacroiliac joints of patients with spondylarthritis. Arthritis Rheum (Arthritis Care Res) 2009; 61(7): 893-9.

202.  Colbert RA, Deodhar AA, Fox D, Gravallese EM, Khan MA, et al. Entheses and Bones in Spondyloarthritis: 2008 Annual Research and Education Meeting of the Spondyloarthritis Research and Therapy Network (SPARTAN), J Rheumatol.2009; 36(7):1527-31.

203.  Olivieri I, D’Angelo S, Palazzi P, Padula A, Mader R, Khan MA. Diffuse Idiopathic Skeletal Hyperostosis: A Condition That Needs to Be Differentiated from Spondyloarthritis. Curr Rheumatol Report. 2009; Oct; 11(5): 321-8.

204.  Magrey M, Khan MA. New insights into SAPHO syndrome. Curr Rheumatol Report. 2009; Oct; 11(5):329-33.

205.  Weber U, Hodler J, Jurik AG,  Pfirrmann CWA, Rufibach K, , Kissling RO, Khan MA, Lambert RGW, Maksymowych WP. Assessment of active spinal inflammatory changes in patients with axial spondyloarthritis: Validation of whole body MRI against conventional MRI. Ann Rheum Dis. 2010; 59: 648-53.

206.  Lipps J, Khan MA. Vogt-Koyanagi-Harada syndrome: A rheumatologic perspective. Int. J Clin Rheumatol. 2010; 5(2): 255-63.

207.  Magrey M, Khan MA. HLA-B27 homozygosity and clinical features of ankylosing spondylitis. Curr Rheumatol Report. 2010; 12: 309-10

208.  Magrey M, Khan MA. Osteoporosis in ankylosing spondylitis. Curr Rheumatol Report. 2010; 12: 332-6

209.  Khan MA. Remarkable Polymorphism of HLA-B27: An Ongoing Saga. Curr Rheumatol Report. 2010; 12: 337-41.

210.  Alabed IE, Qushmaq KA, Khan MA. Psoriasis induced by infliximab in a Saudi patient with ankylosing spondylitis. Saudi Med J 2010; Sep;31(9):1054-6.

211.  Ozgocmen S, Akgul O, Khan MA. Mnemonic for assessment of the spondyloarthritis international society criteria. J Rheumatol. 2010 Sep;37(9):1978.

212.  Antonelli M, Bupathi M, Janakiram M, Khan MA. Acquired erythrocytosis on treatment with infliximab for ankylosing spondylitis. J Rheumatol. 2011 Mar 38(3):581-3

213.  Khan MA. Ankylosing spondylitis and related spondyloarthropathies: the dramatic advances in the past decade.  Rheumatology 2011; 50: 637-9.

214.  Braun J, van den Berg R, Baraliakos X, …., Khan MA, ...., van der Heijde D. 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis (AS). Ann Rheum Dis. 2011; June: 70(6):896-904.

215.  Khan MA, Garcia-Kutzbach A, Espinoza LR. Treatment of ankylosing spondylitis: A critical reappraisal of nonsteroidal antiinflammatory drugs and corticosteroids. Am J Med Sciences. 2012 May; 343(5):350-2.

216.  Mustafa KN, Hammoudeh M, Khan MA. HLA-B27 prevalence in Arab populations and among patients with ankylosing spondylitis. J  Rheumatol. 2012, Aug: 39(8):1675-7.

217.  Ozgocmen S, Khan MA. Current concept of spondyloarthritis: Special emphasis on early referral and diagnosis. Curr Rheumatol Report. 2012, Oct; 14(5):409-14. Erratum: 2012 Dec; 14(6):624.  

218.  Magrey M, Antonelli M, James N, Khan MA. High frequency of fibromyalgia in patients with psoriatic spondylitis: A pilot study. Arthritis 2013, Published online February 14. 4 pages Article ID 762921

219.  Arnold LM, Fan J, Russell IJ, Yunus MB, Khan MA, Kushner I, et al. The fibromyalgia family study: A genome-scan linkage study. Arthritis Rheum. 2013; April: 65(4): 1122-8.

220.  Lim D, James N, Sobia H, Khan MA. Arthritis associated with acne conglobata, hidradenitis suppurativa and dissecting cellulitis of the scalp: A review with illustrative cases. Curr Rheumatol Report. 2013, Aug; 15(8):346. doi: 10.1007/s11926-013-0346-y.

221.  Khan MA. Polymorphism of HLA-B27: 105 subtypes currently known. Curr Rheumatol Report. 2013. October (15)10:362. doi 10.1007/s11926-013-0362-y

222.  Bao C, Huang F, Khan MA, et al.  Safety and efficacy of golimumab in Chinese patients with active ankylosing spondylitis: 1-year results of a multicentre, randomized, double-blind, 5 placebo-controlled phase III trial. Rheumatology 2014; 53:1654-83.

223.  Magrey M, Khan MA. Gene-gene interactions of HLA-B27 and ERAP1 in ankylosing spondylitis: Finding the pieces of the puzzle. Int. J Clin Rheumatol. 2014; 9(6):539-42.

224.  Kiltz U, van der Heijde D, Boonen A, Cieza A, Stucki G, Khan MA, et al. Development of a health index in patients with ankylosing spondylitis (ASAS HI): Final result of a global initiative based on the ICF guided by ASAS. Ann Rheum Dis. 2015; 74(5):830-5.

225.  Akkoc N, Khan MA: Looking into the new ASAS Classification Criteria for axial spondyloarthritis through the other side of the glass. Curr Rheumatol Rep.. 2015;17(6):515. doi: 10.1007/s11926-015-0515-2.

226.  Antonelli M, Khan MA, Magrey M. Differential adverse events between TNF-α inhibitors and IL-17 axis inhibitors for the treatment of spondyloarthritis. Curr Treatment Options in Rheumatol. 2015; Jun;1(2): 239-54. doi: 10.1007/s40674-015-0022-7.

227.   van der Linden S, Akkoc N, Brown MA, Robinson PC, Khan MA. The ASAS criteria for axial spondyloarthritis: strengths, weaknesses and proposals for a way forward. Curr Rheumatol Report. 2015;17(9):535. doi: 10.1007/s11926-015-0535-y

228.  Khan MA, Haroon M, Rosenbaum JT.  Acute Anterior Uveitis and Spondyloarthritis: More Than Meets The Eye. Curr Rheumatol Rep. 2015;17(9): 536.   doi: 10.1007/s11926-015-0536-x

229.  Akkoc N, Khan MA: ASAS Classification Criteria for axial spondyloarthritis: time to modify. Clin Rheumatol  2016;35(6):1415-23.

230.  Khan MA. Accomplishments of Heinz Baumberger PhD: a remarkable patients with ankylosing spondylitis for 72 years. Clin Rheumatol 2016;35(6):1637-41.

231.  Magrey M, Lewis S, Khan MA. Utility of DXA scanning and risk factors for osteoporosis in ankylosing spondylitis -- A prospective study. Semin Arthritis Rheum 2016;46:88-94.

232.  Kiltz U, van der Heijde D, Boonen A, Bautista-Molano W, Burgos-Vargas R, Chiowchanwisawakit P, Duruoz T, El-Zorkany B, Essers I, Gaydukova I, Géher P, Gossec L, Grazio S, Gu J, Khan MA et al. Measuring impairments of functioning and health in patients with axial spondyloarthritis by using the ASAS Health Index and the Environmental Item Set: translation and cross-cultural adaptation into 15 languages. RMD Open. 2016 Oct 4;2(2):e000311

233.  van der Linden S, Khan MA. Can we currently and confidently assess the true burden of illness due to nonradiographic  axial spondyloarthritis? (Editorial). Clin Exp Rheumatol. 2016 Nov-Dec;34(6):963-965. Epub 2016 Nov 28.

234.  Khan MA. An Update on the Genetic Polymorphism of HLA-B*27 with 213 Alleles Encompassing 160 Subtypes (and Still Counting). Curr Rheumatol Rep. 2017 Feb;19(2):9. doi: 10.1007/s11926-017-0640-1.

235.  Magrey M, Khan MA. The paradox of bone formation and bone loss in ankylosing spondylitis: Evolving new concepts of bone formation and future trends in management. Curr Rheumatol Rep. 2017 Apr;19(4):17. doi: 10.1007/s11926-017-0644-x.

236.  Akkoc N,  Yarkan H, Kenar G, Khan MA. Ankylosing Spondylitis: HLA-B*27 Positive versus HLA-B*27 Negative Disease. Curr Rheumatol Rep. 2017 May;19(5):26. doi: 10.1007/s11926-017-0654-8.

237.  Bilal J, Riaz IB, Kamal MU, Elyan M, Sudano D, Khan MA. Systematic Review and Meta-Analysis of Efficacy and Safety of Novel Interleukin Inhibitors in the Management of Psoriatic Arthritis. J Clin Rheumatol. 2018 January;24:6-13.

238.  Magrey M, Khan MA. Relationship between disease activity measures, functional status, and fibromyalgia symptom scale in ankylosing spondylitis: a cross-sectional study. (Submitted for publication)

LETTERS TO EDITOR:

 1.     Khan MA, Kushner I, Braun WE:  Low incidence of HLA‑B27 in American Blacks with spondyloarthropathies.  Lancet 1976; i: 483.

 2.     Khan MA, Ricanati ES, Chung‑Park MJ:  Lupus nephritis and renal vein thrombosis. Ann Intern Med. 1977; 86: 114.

 3.     Khan MA, Kushner I, Braun WE, Schacter BZ, Steinberg AG:  HLA‑B7 and ankylosing spondylitis in American Blacks.  N Engl J Med 1977; 297: 513.

 4.      Khan MA:  Ankylosing spondylitis and HLA‑B27 in Punjabis.  Lancet 1977; ii: 504.

 5.      Khan MA, Ganuza C:  Ruptured popliteal cyst and thrombophlebitis. Arthritis Rheum 1977; 20: 1561‑2.

 6.      Braun WE, Dejelo CL, Clough JF, Beck KA, Schacter BZ, Khan MA:  No association of known DR antigens with ankylosing spondylitis.  N Engl J Med 1978; 298: 744‑5.

 7.      Khan MA, Kushner I, Braun WE:  B27‑negative HLA‑Bw16 in ankylosing spondylitis. Lancet  i: 1978; 1370‑1.

 8.      Khan MA, Kushner I, Ballou SP, Braun WE: Familial rheumatoid arthritis and HLA‑DRw4. Lancet 1979; i: 921‑2.

 9.      Hammoudeh M, Khan MA, Kushner I:  Unilateral rheumatoid arthritis. Arthritis Rheum  1981; 24:1218.

10.    Hammoudeh M, Khan MA:  Clinical variants of systemic lupus erythematosus resembling multiple sclerosis. J Rheumatol 1982; 9:336‑8.

11.     Yue CC, Khan MA:  HLA antigens and diffuse idiopathic hyperostosis.  N Engl J Med 1983; 309: 924.

12.     Khan MA:  HLA antigens and acute anterior uveitis.  J Rheumatol 1984; 11: 556‑7.

13.    Khan MA:  HLA haplotypes in multiple case families with rheumatoid arthritis. Clin Rheumatol 1984; 3: 557.

14.    van der Linden SM, Khan MA:  The risk of ankylosing spondyltis in HLA‑B27 positive individuals.  Reply.  J Rheumatol 1986; 13: 220‑2.

15.    van der Linden SM, Khan MA:  On the prevalence of ankylosing spondylitis. Reply. J Rheumatol 1986; 13: 222‑224.

16.    Khan MA, Sun JP, Bahler RC:  Echocardiographic evidence of altered cardiac diastolic function in ankylosing spondylitis.  Lancet  1987; i: 1501.

17.    Bluestone R, Khan MA, Ellis M, Sears MA:  Ankylosing Spondylitis Association. J Rheumatol 1988; 15: 154‑5.

18.    Yagan R, Khan MA, Radivoyevitch MA:  Double acetabular line.  Reply.  Radiology 1988; 167: 873‑4.

19.     Reynolds TL, Khan MA:  HLA‑B27 and the putative susceptibility gene for ankylosing spondylitis J Rheumatol 1988; 15: 1037‑8.

20.     Reynolds TL, Khan MA:  B7 cross‑reactive antigens in spondyloarthropathies. J Rheumatol 1988; 15: 1454.

21.     Iskander M, Khan MA:  Candida albicans infection of a prosthetic knee replacement.                    J Rheumatol 1988; 15:1594‑5.

22.     Iskander M, Khan MA:  Chorea as the initial presentation of oral contraceptive related systemic lupus erythematosus.  J Rheumatol 1989; 16: 850‑1.

23.     Khan MA:  HLA‑B27 and B12 (B44) in Crohn's disease patients with ankylosing spondylitis.                    J Rheumatol 1989; 16:851‑2.

24.     Khan MA, Yagan R:  Sacroiliac abnormalities in DISH.  J Rheumatol 1989; 16: 1399.


25.     Khan MA:  Genetic predisposition to rheumatoid arthritisN Engl J Med 1990; 323: 996.

26.     van den Borne B, van Laere G, Khan MA: Tendon rupture in systemic lupus erythematosus.        J Rheumatol 1990; 17: 1571.

27.     Khan MA:  HLA‑B27 and arthritis:  Back to the future. J Rheumatol 1991; 18:1638.

28.     Yagan R, Khan MA:  The coexistence of ochronosis and ankylosing spondylitis. J Rheumatol 1991; 18: 1639-40.

29.         Khan MA: Delay in the radiographic detection of sacroiliitis in ankylosing spondylitis. (Comments on the article by Lipsky and Taurog). Arthritis Rheum 1992; 35:727.

30.         Khan MA: First International Congress on Spondyloarthropathies: Focus on Pathogenic, Clinical, and Therapeutic Aspects. Rheumatology 1998; 12(3):8-11.

31.         Khan MA. Ankylosing spondylitis or ankylosing hyperostosis. BMJ vol 319; Letter to Editor (eletter), July 1999. http://bmj.bmjjournals.com/cgi/eletters/319/7203/171#3975.

32.         Khan MA:  Comments on the article by Sweeny et al: Total hip arthroplasty in ankylosing spondylitis. J Rheumatol 2002; 29:1342.

33.         Akkoc N, Khan MA:  Overestimation of the prevalence of ankylosing spondylitis in the Berlin study: Comment on the article by Braun et al. Arthritis Rheum 2005; 52(12):4048-9.

34.         Akkoc N, Khan MA: ASAS classification criteria for axial spondyloarthritis: a look at the unfilled part of the glass. Clin Exp Rheumatol. 2014; 32(6). Suppl.87: S14-S15.

35.         Akkoc N, Khan MA: Radiographic axial spondyloarthritis versus ankylosing spondylitis. Clin Exp Rheumatol. 2015; Aug 27 [Epud ahead of print]

36.        Akkoc N, Khan MA: Treatment of Patients With Nonradiographic Axial Spondyloarthritis Who Have Negative Magnetic Resonance Imaging Results and Normal C-Reactive Protein Levels at Baseline: Comment on the Article by Ward et al. Arthritis Rheumatol  2016;Jun;68(6):1563.   (and Arthritis Care Research 2016;Jun;68(6):886)

37.        van der Linden S, Khan MA. Axial spondyloarthritis in relatives of probands with ankylosing spondylitis. Comments on the article by Turina et al. Arthritis Rheumatol. 2016 Dec 21. doi: 10.1002/art.40026. [Epub ahead of print]

SCIENTIFIC ABSTRACTS:


1.          Khan MA, Braun WE, Kushner I: Low frequency of HLA‑B27 in American Blacks with ankylosing spondylitis. Clin Res 25: 331A, 1976.

2.          Khan MA, Kushner I, Braun WE: A comparison of clinical features in HLA‑B27 positive and negative patients with ankylosing spondylitis.  Arthritis Rheum 19: 804‑805, 1976.

3.          Goldberg M, Khan MA, Kushner I, Powell E: Plasma dependent impaired lymphocyte responsiveness in ankylosing spondylitis.  Arthritis Rheum 19: 798, 1976.

4.          Khan MA, Braun WE, Kushner I, Steinberg AG: Low prevalence of HLA‑B27 in American Blacks with ankylosing spondylitis. HLA and Disease, Abstracts. Paris, Editions INSERM, p. 40, 1976.

5.          Khan MA, Kushner I, Braun WE, Grecek DE, Steinberg AG: HLA‑B27 homozygosity in  ankylosing spondylitis: Relationship to risk and severity.  Clin Res 25: 362A, 1977.

6.          Khan MA, Kushner I, Braun WE, Grecek DE, Steinberg AG: HLA‑B27 homozygosity in ankylosing spondylitis: Relationship to risk and severity. XIV International Congress of Rheumatology Abstracts. San Francisco, p.165, 1977.

7.          Khan MA, Kushner I, Braun WE:  Association of HLA‑B7 with ankylosing spondylitis in HLA‑B27 negative American Black patients.  Clin Res 25: 582A, 1977.

8.          Khan MA, Kushner I, Freehafer AA:  Sacroiliac joint abnormalities in paraplegics.  Fourth Annual Meeting of the Central Rheumatism Association, Abstracts, Snowmass, Colorado, January 15‑16, 1978.

9.          Khan MA, Kushner I, Braun WE:  Association of HLA‑B7 with ankylosing spondylitis in HLA‑B27 negative American Black patients.  Fourth Annual Meeting of the Central Rheumatism Association, Abstracts, Snowmass, Colorado, January 15‑16, 1978.

10.      Khan MA, Kushner I, Braun WE:  A subgroup of ankylosing spondylitis associated with HLA‑B7 in American Blacks.  Arthritis Rheum 21: 569‑570, 1978.

11.      Khan MA, Askari AD, Braun WE, Aponte CJ:  Reiter's syndrome: Diagnostic value of HLA‑B27 in Whites and Blacks and a comparison of clinical features in B27(+) and B27(‑) patients. VII Pan American Congress of Rheumatology, Abstracts, Bogota, Columbia, p. 56, 1978.

12.      Khan MA, Khan MK:  Decreased survival in ankylosing spondylitis: A life‑table analysis. Clin Res 26: 673A, 1978.

13.      Khan MA, Khan MK, Kushner I:  Evidence of decreased survival in ankylosing spondylitis by life‑table analysis. Arthritis Rheum 22: 628, 1979.

14.      Campbell PB, Khan MA, Kushner I:  Demonstration of a monocyte leukotactic defect in ankylosing spondylitis. Arthritis Rheum 22: 597, 1979.

15.      Khan MA, Kushner I, Braun WE:  Genetic heterogeneity in primary ankylosing spondylitis. Arthritis Rheum 22:628, 1979.

16.      Khan MA, Kushner I, Braun WE:  Association of HLA‑A2 with uveitis in HLA‑B27 positive patients with ankylosing spondylitis.  Clin Res 28: 141A, 1980.

17.      Khan MA, Kushner I, Braun WE, Ballou SP:  Clinical and HLA Studies of familial rheumatoid arthritis.  Clin Res 28: 141A, 1980.

18.      Khan MA, Braun WE, Steinberg AG, Kushner I, Dejelo CL, Ballou SP:  HLA studies of familial rheumatoid arthritis. Clin Res 28: 29A, 1980.

19.      Khan MA, Kushner I, Braun WE:  Association of HLA‑A2 with uveitis in HLA‑B27 positive patients with ankylosing spondylitis.  Arthritis Rheum 23: 703, 1980.

20.      Khan MA, Braun WE, Steinberg AG, Kushner I, Dejelo CL, Ballou SP:  Clinical and HLA studies in familial rheumatoid arthritis.  Arthritis Rheum 23: 702‑703, 1980.

21.      Nunez G, Moore S, Ball GV, Hurd E, Khan MA, Stastny P:  The inheritance of HLA haplotypes in families with adult rheumatoid arthritis.  Arthritis Rheum 23: 726, 1980.

22.      Khan MA, Miron SD, Patel S, Kushner I, Ballou SP, Wiesen E, Bellon E:  The comparative value of standard radiography, quantitative scintigraphy and computerized tomography in sacroiliitis.  Clin Res 28: 778A, 1980.

23.      Khan MA, Braun WE, Steinberg AG, Kushner I, Dejelo CL, Ballou SP:  HLA studies of familial rheumatoid arthritis. Abstract No. 8.5.31, 4th International Congress of Immunology, Paris, 1980.

24.      Khan MA, Kushner I, Braun WE:  Association of HLA‑A2 with uveitis in HLA‑B27 positive patients with ankylosing spondylitis.  Abstract No. 8.5.32, 4th International Congress of Immunology, Paris, 1980.

25.      Khan MA, Miron SD, Kushner I, Ballou SP, Wiesen EJ, Bellon EM:  The comparative value of standard radiography, quantitative scintigraphy and computerized tomography in sacroiliitis.  Arthritis Rheum 24(Supplement): S119, 1981.

26.      Ballou SP, Khan MA, Kushner I:  Clinical features of lupus: differences related to age of onset and race.  Arthritis Rheum 24(Supplement): S120, 1981.

27.      Miron SD, Khan MA, Wiesen EJ, Kushner I, Bellon EM:  An improved technique for quantitative sacroiliac scintigraphy.  Proceedings of the 29th Annual Meeting of the Association of University Radiologists, p. 35, 1981.

28.      Khan MA, Braun WE:  Acute anterior uveitis in Asian‑American patients with ankylosing spondylitis.  Clin Res 30: 472A, 1982.

29.      Khan MA, Kushner I, Weitkamp LR:  Genetics of HLA‑associated disease: Rheumatoid arthritis.  Clin Res 30: 292A, 1982.

30.      Khan MA, Braun WE: Acute anterior uveitis in Reiter's syndrome: The influence of HLA‑B27 and race.  Clin Res 30: 472A, 1982.

31.      Khan MA, Kushner I, Weitkamp LR: Genetics of HLA‑associated disease: Rheumatoid arthritis.  Arthritis Rheum 25: S136, 1982.

32.      Khan MA, Braun WE: Acute anterior uveitis in Reiter's syndrome: The influence of HLA‑B27 and race.  Arthritis Rheum 25: S134, 1982.

33.      Khan MA, Hammoudeh M: Genetics of HLA‑associated diseases: ankylosing spondylitis and related spondyloarthropathies.  Clin Res 30: 806A, 1982.

34.      Ballou SP, Khan MA, Kushner I, Braun WE: HLA‑DR3 is not associated with antibodies to DNA.  Clin Res 30: 803A, 1982.

35.      Khan MA, Braun WE: Acute anterior uveitis in ankylosing spondylitis: The influence of HLA and race.  Aust NZ J Med 12: 563, 1982.

36.      Khan MA, Braun WE: Acute anterior uveitis in Reiter's syndrome: The influence of HLA‑B27 and race.  Aust NZ J Med 12: 563‑564, 1982.

37.      Khan MA, Hammoudeh M, Braun WE, Kushner I: Genetics of HLA‑associated diseases: Ankylosing spondylitis and related spondyloarthropathies. Aust NZ J Med 12: 564, 1982.

38.      Khan MA, Jumshyd A: Ankylosing hyperostosis in American Blacks: A prospective study.  Aust NZ J Med 12: 564, 1982.

39.      Khan MA, Kushner I, Weitkamp LR: Genetics of HLA‑associated disease: Rheumatoid arthritis.  Aust NZ J Med 12: 564‑565, 1982.

40.      Khan MA, Hammoudeh M: Genetics of HLA‑associated diseases: ankylosing spondylitis and related spondyloarthropathies.  Clin Res 31: 450A, 1983.

41.      Raum D, Awdeh ZL, Glass D, Coblyn JS, Weinblatt M, Holdsworth D, Strong L, Rossen R, Kammer G, Khan MA, Yunis EJ, Alper CA: Extended haplotypes of chromosome six in adult rheumatoid arthritis.  Clin Res 31:493A, 1983.

42.      Khan MA, Hammoudeh MK: Genetics of HLA‑associated diseases: ankylosing spondylitis and related spondyloarthropathies.  Arthritis Rheum 26: S18, 1983.

43.       van der Linden S, Cats A, Valkenburg HA, Khan MA:  Evaluation of the diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria.  Clin Res 1983; 31: 734A.

44.      van der Linden SJ, Cats A, Valkenburg HA, Khan MA. Evaluation of the diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria. Br J Rheumatol. 1984;23:148.

45.      Yamashita TS, Khan MA, Kushner I: Pedigree analysis of 24 multiple‑case families with rheumatoid arthritis.  Clin Res 31: 735A, 1983.

46.      Khan MA, Yamashita TS, Kushner I: Genetic linkage studies of familial rheumatoid arthritis.  Clin Res 31: 784A, 1983.

47.      Ballou SP, Khan MA, Kushner I:  Studies of monocyte Fc receptor‑mediated phagocytic activity in ankylosing spondylitis.  Clin Res 31: 801A, 1983.

48.      Khan MA, Yamashita TS, Kushner I: Genetic linkage studies of familial rheumatoid arthritis.  Ann Rheum Dis 43: 118, 1984.

49.      Khan MA, van der Linden S, Kushner I: Symptomatic ankylosing spondylitis without radiographic sacroiliitis in B27‑positive relatives.  Arthritis Rheum 27: S31, 1984.

50.      Khan MA, Yamashita TS, Kushner I: Genetic analysis of 24 multiple case families with rheumatoid arthritis. Arthritis Rheum 27: S26, 1984.

51.      van der Linden Sj, Valkenburg HA, Cats A, Khan MA, Kushner I:  Symptomatic ankylosing spondylitis without radiographic sacroiliitis in B27‑positive relatives. Br J Rheumatol 23: 148, 1984.

52.      Ballou SP, Khan MA, Kushner I, Zachary A, Braun WE: Association of systemic lupus erythematosus with HLA‑Cw7.  Clin Res 32: 755A, 1984.

53.      Ballou SP, Khan MA, Kushner I: Studies of monocyte phagocytic function in ankylosing spondylitis.  Clin Res 32: 756A, 1984.

54.      Payami H, Khan MA, Thomson G: Family and population studies of inheritance of rheumatoid arthritis.  Clin Res 32: 758A, 1984.

55.      Ballou SP, Khan MA, Kushner I: Prospective evaluation of intravenous pulse methylprednisolone followed by alternate‑day corticosteroid therapy in systemic lupus erythematosus.  Clin Res 32: 819A, 1984.

56.      Khan MA, Yamashita TS, Kushner I:  The mode of inheritance of rheumatoid arthritis. Human Immunology 12: 120‑121, 1985.

57.      Payami H, Khan MA, Thomson G: Family and population studies of inheritance of rheumatoid arthritis.  Human Immunology 12: 121, 1985.

58.      Ballou SP, Khan MA, Kushner I: Studies of monocyte phagocytic function in ankylosing spondylitis.  Arthritis Rheum 28(Supplement): S50, 1985.

59.      van der Linden S, Valkenburg H, Cats A, Khan MA: Are women relatively protected from developing ankylosing spondylitis?  Arthritis Rheum (Supplement) 594, 1985.

60.      Khan MA, Reynolds TL, Ballou SP, Kushner I:  HLA haplotype distribution in familial rheumatoid arthritis. Clin Res 33: 920A, 1985.

61.      Ballou SP, Khan MA, Braun WE, Kushner I:  Association of the HLA‑C allele, Cw7, with systemic lupus erythematosus.  Clin Res 33: 916A, 1985.

62.      Khan MA, Khan MK: Evidence for an HLA‑linked susceptibility gene in rheumatoid arthritis.  Clin Res 34: 618A, 1986; Arthritis Rheum 29: S103, 1986; Br J Rheumatol 25(Supplement): Abstract No. 50, 1986.

63.      Wolfe F, Kleinheksel SM, Khan MA:  Familial rheumatoid arthritis: Epidemiological and clinical features. Arthritis Rheum 30:(Supplement 1), S18, 1987. Also PANLAR 1986 Meeting Abstract Book, p. 161 (Abstract B60), 1986.

64.      Khan MA:  Immunogenetics of seronegative polyarthritis.  Clinically oriented aspects. EULAR Symposium Rome1986 Meeting Abstract Book, p. 40, 1986.

65.      van der Linden SJ, Rentsch HU, Gerber N, Khan MA, Cats A, Valkenburg HA:  An increased prevalence of thoracic spine pain in HLA‑B27 positive relatives of patients with ankylosing spondylitis: A confirmative report.  EULAR Symposium Rome 1986 Meeting Abstract Book, p. 63, 1986.

66.      Khan MA, Wolfe F, Kleinheksel SM, Khan MK:  Immunogenetic and epidemiologic studies in non‑familial and familial rheumatoid arthritis.  Fed Proc 46(Supplement 3): 426, 1987.

67.      Sun J‑P, Khan MA, Bhaler RC: Impairment of cardiac diastolic function in patients with ankylosing spondylitis, as evaluated by Doppler echocardiography. Br J Rheumatol 26(Supplement 1): 71, 1987.

68.      Khan MA, Wolfe F, Kleinheksel SM, Khan MK: Clinical, epidemiological and immunogenetic studies of familial and non‑familial rheumatoid arthritis. Br J Rheumatol 26(Supplement 1): 43, 1987.

69.      van der Linden S, Cats A, Goe The HS, Khan MA:  Proposals for revision of diagnostic criteria for ankylosing spondylitis (AS).  Arthritis Rheum 30(Supplement 4): S75, 1987.

70.      Khan MA, Sun J‑P, Bahler RC:  Impairment of cardiac diastolic function in patients with ankylosing spondylitis (AS), as evaluated by Doppler echocardiography. Arthritis Rheum 30(Supplement 4): S74, 1987.

71.      Ball EJ, Dombrausky L, Hoover M, Pincus T, Olsen N, Khan MA, Capra JD, Stastny P: Rheumatoid arthritis is associated with a polymorphic restriction fragment of the human T cell receptor gene Arthritis Rheum 30 (Supplement 4): S26, 1987.

72.      Yamashita TS, Khan MA, Wolfe E, Stastny P:  Genetic epidemiology of familial rheumatoid arthritis (RA): Study of 70 multi‑case families.  Am J Hum Genet 41(Supplement 3): A264, 1987.

73.      Khan MA, Yamashita TS, Stastny P, Wolfe F, Kleinheksel S, Khan MK: Familial rheumatoid arthritis and homozygosity for HLA‑DR4.  Arthritis Rheum 31(Supplement 1): R29, 1988.

74.      Khan MA, Yamashita TS, Wolfe F, Kleinheksel S, Khan MK:  Effect of gender and HLA‑DR4 genotype in familial rheumatoid arthritis.  Arthritis Rheum 31(Supplement 1): R31, 1988.

75.      Mackiewicz A, van der Linden S, Khan MA, Kushner I:  Serum IgA and acute phase proteins in HLA B27(+) versus B27(‑) ankylosing spondylitis.  Arthritis Rheum 31(Supplement 1): R29, 1988.

76.      Mackiewicz A, van der Linden S, Reynolds TL, Khan MA, Kushner I:  Positive correlation between serum levels of IgA and acute phase proteins (APP) suggests a pathogenic role of gastrointestinal (GI) inflammation in ankylosing spondylitis (AS). Arthritis Rheum 31(Supplement 4): S96, 1988.

77.      Robinson WP, van der Linden S, Khan MA, Thomson G:  A B27/Bw60 interaction effect for ankylosing spondylitis among Caucasians.  Arthritis Rheum 31(Supplement 4): S112, 1988.

78.      Shah Z, Khan MA, Green H, Rashad F:  Study of articular cartilage and para‑articular soft tissue structures of shoulder joints by ultrasonography in rheumatoid arthritis patients and controls.  J Ultrasound Med 7(Supplement 10): S245, 1988.

79.      Reynolds TL, Khan MA, van der Linden S, Cleveland RP, Mackiewicz A:  HLA‑B27 and clinical disease activity correlate with serum IgA and acute phase proteins in ankylosing spondylitis patients.  Arthritis Rheum 32(Supplement): S47, April 1989.

80.      Mackiewicz A, Khan MA, Calabrese L, Espinoza LF:  N‑glycan microheterogeneity of α1‑acid glycoprotein in HIV infected patients with and without arthritis. Arthritis Rheum 35(Supplement):S86, September 1992.

81.      Khan MA, Buniel J:  Genetic studies of anti‑Ro (SS‑A) and other autoantibodies in white families with multiple cases of rheumatoid arthritis.  Arthritis Rheum 35(Supplement):S285, September 1992.

82.      Yunus MB, Rawlings KK, Khan MA:  A study of multicase families with fibromyalgia with HLA typing. Arthritis Rheum 35(Supplement):S285, September 1992.

83.      McDermott M, Kastner DL, Holloman J, Schmidt-Wolf G, Lundberg A, Sinha A, Amos C, Khan MA, Wolfe F, Rubin L, Mulcahy B, Cashin P, Molloy MGM, Clegg R, Ward R, McDevitt HO.  Segregation of TCRß chain haplotypes in multiplex rheumatoid arthritis families. Presented at Keystone Symposium on Molecular and Cellular Biology. January, 1993.

84.      Rubin LA, McDermott M, Kastner DL, ..., Khan MA, et al:  The role of T cell receptor ß chain haplotypes in conferring genetic susceptibility to rheumatoid arthritis. Arthritis Rheum 36(Supplement):S197, September 1993.

85.      Khan MA, Mustafa KN, Ayoubi N:  Epidemiologic approach to inflammatory bowel disease and spondyloarthropathy.  Clin Exp Rheumatol 12:99, 1994.

86.      Khan MA:  HLA-B27 heterogeneity.  Clin Exp Rheumatol 12:105, 1994.

87.      Khan MA:  The impact of HLA-B27 subtype on the occurrence of spondyloarthropathies. Scand J Rheumatol Supplement 98, Abstract 235, 1994.

88.      Yunus MB, Rawlings KK, Khan MA, Green JR. Genetic studies of multicase families with fibromyalgia syndrome. Arthritis Rheum 38 (Supplement):S247,1995.

89.      Reveille J, Fraser P, Taurog J, Pollack M, Ahearn J, Khan MA, Appleyard J, Arnett F. HLA-B27 subtypes in African Americans with spondyloarthropathy (SpA). Arthritis Rheum 39 (Supplement):S 204,1996.

90.      Yunus MB, Rawlings KK, Khan MA, Green JR. Fibromyalgia syndrome (FMS): Evidence of genetic linkage to HLA. Arthritis Rheum 39 (Supplement):S275,1996.

91.      van der Heijde D, Bellamy N, Calin A, Dougados M, Khan MA, van der Linden S. Preliminary core sets for endpoints in ankylosing spondylitis. Arthritis Rheum 40 (Supplement):S62,1997.

92.      Khan MA. The twenty HLA-B27 subtypes – B*2701 to B*2720. J Rheumatol  27(Supplement 59): p. 29, 2000.

93.      Reveille JD, Inman R, Khan MA. et al. Family studies in ankylosing spondylitis. J Rheumatol  27 (Suppl 59):5, 2000.

94.      Reveille JD, Bruckel J, Inman R, Weisman M, Khan MA. et al. Genetic studies in ankylosing spondylitis. Arthritis     Rheum 43(Supplement):S2666, 2000.

95.      Benjamin M, Bollow M, Braun J, ….. ,Khan MA, …., Poole AR. Anatomy and biochemistry of entheses. Ann Rheum Dis 59: 995-999, 2000.

96.      Reveille JD, Bruckel J, Inman R, Weisman M, Khan MA, et al. Genetic studies in familial ankylosing spondylitis: The North American Spondylitis Consortium experience. Ann Rheum Dis 60(suppl. I): p 6, July 2001.

97.      Khan MA. Update on psoriasis as it relates to spondyloarthropathies. Ann Rheum Dis 60(suppl. I): p 6, July 2001.

98.      Reveille JD, Bruckel J, Inman R, ……Khan MA, ..…et al. Evidence for a second major histocampatibility complex (MHC) in predisposition to familial ankylosing spondylitis (AS) [Abstract #1116]. Arthritis Rheum 2001; 44 (suppl.): 1111.

99.      Khan MA, Akey J, Bruckel J, Weisman MH, Inman RD, Stone M, et al. HLA-DRB1*0101 and DRB1*1501 but not HLA-B60 (B*4001) Contribute to Susceptibility to Ankylosing Spondylitis (AS) Arthritis Rheum 2002; 46 [No. 9 (suppl.)]: S435.

100.  Reveille JD, Akey J, Bruckel J, Weisman M, Inman RD, Stone M, ----- Khan MA, ----- Jin L. Definite evidence for at least one other major histocompatibility complex (MHC) gene in addition to HLA-B27 in predisposition to ankylosing spondylitis. Arthritis Rheum 2002; 46 (No. 9 (suppl.)): S392.

101.  Reveille JD, Akey J, Bruckel J, Weisman MH,…Khan MA, ..Jin L. The Interleukin Receptor-1 Antagonist (IL-1RA) gene is implicated in predisposition to ankylosing spondylitis (AS). Arthritis Rheum 2002; 46: No. 9(suppl.): S620.

102.  Rudwaleit M, Braun J, Khan MA, van der Heijde D, Sieper J. Early diagnosis of ankylosing spondylitis. Ann Rheum Dis 2003; June (Suppl.), 54.

103.  Yunus MB, Arnold L, Iyengar SK, Khan MA, et al. Associated Phenotypes in Familial Fibromyalgia Syndrome (FMS): A Preliminary Report from the Fibromyalgia Family Study Group (FFSG). Arthritis Rheum 2003; 48: #9 (suppl.), S86-S87.

104.  Arnold LM, Iyengar SK, Khan MA, et al. Genetic linkage of Fibromyalgia to the Serotonin Receptor 2A Region on Chromosome 13 and the HLA region on Chromosome 6. Arthritis Rheum 2003; 48: #9 (suppl.), S228-S229

105.  Lee J, Jingchun L, Bruckel J, Inman R, Mahowald M, Weisman M, Schumacher R, Khan MA, et al. A Genome Scan for Ankylosing Spondylitis Susceptibility. Arthritis Rheum 2003; 48: #9 (suppl.), S224.

106.  Reveille JD, Lee J, Bruckel J, Weisman M, Khan MA et al. Fine Mapping of Candidate Susceptibility Regions in Ankylosing Spondylitis on Chromosome 11q. Arthritis Rheum 2003; 48: #9 (suppl.), S224.

107.  Reveille JD, Lee J, Bruckel J, Weisman M, Khan MA et al. Fine Mapping of Candidate Susceptibility Regions in Ankylosing Spondylitis on Chromosome 6q25. Arthritis Rheum 2003; 48: #9 (suppl.), S224-S225.

108.  Rudwaleit M, Braun J, Khan MA, van der Heijde D, Sieper J. How to diagnose spondyloarthritis early? Arthritis Rheum 2003; 48: #9 (suppl.), S174.

109.  Reveille JD, Zhang G, Bruckel J, Weisman MH, Bruckel  J, Schumacher, HR, Khan MA et al. The haplotype HLA-B*0700, DRB1*1501, DQA1*0102, DQB1*0602 augments the risk of the development of ankylosing spondylitis in addition to HLA-B27. Arthritis Rheum 2004 49: #9 (suppl.), S259.

110.  Reveille JD, Zhang G, Bruckel J, Weisman MH, Bruckel  J, Schumacher, HR, Khan MA et al. Interaction of a region on Chromosome 11q23 and the HLA-DPB1 locus influences susceptibility to ankylosing spondylitis. Arthritis Rheum 2004 49: #9 (suppl.), S449.

111.  Martin TM, Zhang G, Luo J, ----, Khan MA et al. A region on Chromosome 9p predisposes to acute anterior uveitis, a specific disease manifestation in ankylosing spondylitis. Arthritis Rheum 2004 49: #9 (suppl.), S448-S449

112.  Martin TM, Reveille JD, Smith JR, -------, Khan MA, Schumacher HR and Rosenbaum JT. The MHC class II haplotype HLA-DRB1*0801/DQA1*0401/DQB1*0402 is associated with acute anterior uveitis. Experimental Biology Meeting, April 2005

113.  Zochling J, van der Heijde D, ------- Khan MA et al. ASAS/EULAR Recommendations for the management of ankylosing spondylitis. Ann Rheum Dis 2005 (EULAR Abstracts) (suppl.)

114.  Rudwaleit M, Landewé R, Brandt J, Burgos-Vargas R, Collantes-Estevez E, Dijkmans B, Dougados M, Khan MA et al. Assessment of Agreement of Expert Opinion on Clinical Features in Axial Spondyloarthritis (SpA). Arthritis Rheum 2005; 52: #9 (suppl.), S637.

115.  Zochling J, van der Heijde D, ------- Khan MA et al. ASAS/EULAR Recommendations for the management of ankylosing spondylitis. Arthritis Rheum 2005; 52: #9 (suppl.), S638-S639.

116.  Rudwaleit M, Landewé R, Brandt J, Burgos-Vargas R, Collantes-Estevez E, Dijkmans B, Dougados M, Khan MA et al. Parameters Contributing to Inflammatory Back Pain (IBP) According to Experts.  Arthritis Rheum 2005; 52: #9 (suppl.), S213.

117.  Reveille JD, Zhang G, Weisman MH, Bruckel J, Inman RD, Khan MA, et al. Evidence for Involvement of the Neural Cell Adhesion Cell (NCAM)-1 Gene in Susceptibility to Ankylosing Spondylitis. Arthritis Rheum 2005; 52: #9 (suppl.), S389.

118.  Albuquerque SM, Zhang G, Zhou X, ---, Khan MA, et al. Association of IL-1 gene with ankylosing spondylitis susceptibility: Evidence from family based analysis. Late breaking abstract. Presented at the ACR 2005 Annual Scientific Meeting.

119.  Braun J, Cook R, Landewe R, ---, Khan MA, et al. INSPIRE Lateral Flexion: A new method to measure lateral spinal mobility in patients with spondyloarthritis. Ann Rheum Dis 2006, 65 (Suppl 2), 208.

120.  Gladman DD, Inman RD, Cook R, ---, Khan MA, et al. International Spondyloarthritis Inter-observer Reliability Exercise – the INSPIRE study. Ann Rheum Dis 2006, 65 (Suppl 2), 217.

121.  Olivieri I, D’Angelo S, Cutro MS, --, Khan MA. Diffuse Idiopathic Skeletal Hyperosotosis. Ann Rheum Dis 2006, 65 (Suppl 2), 640.

122.  Zhou X, Xiong M, Weisman MH, Inman RD, Khan MA, et al. Genetic studies of the Interleukin-1A, CTGF, DRB1, DQA1, DQB1, DPB1, HLA-B and HLA-A in multiple ankylosing spondylitis families. Arthritis Rheum 2007; ACR Annual Meeting Abstract suppl, p S45.

123.  Gladman DD, Inman RD, Cook R, ---, Khan MA, et al. Composite indices for disease activity in ankylosing spondylitis and psoriatic arthritis. Arthritis Rheum 2007; ACR Annual Meeting Abstract suppl, p S481.

124.  Weber U, Maksymowych WP, Jurik AG, Pfirrmann CWA, Kissling RO, Khan, MA, Hodler J. Validation of whole body MRI against conventional MRI for scoring inflammatory lesions in the sacroiliac joints of patients with spondyloarthritis. Presented at EULAR 2008 Meeting in Paris, France. Ann Rheum Dis 2008, (Suppl) and also presented at ACR Annual Meeting in San Francisco, October 24 – 29, 2008.

125.  Weber U, Hodler J, Jurik AG, Pfirrmann CWA, Kissling RO, Khan, MA, Maksymowych WP. Validation of whole body MRI against conventional MRI for scoring inflammatory changes in the entire spine in spondyloarthritis. Presented at EULAR 2008 Meeting in Paris, France. Ann Rheum Dis 2008, (Suppl). It was also presented at the ACR Annual Meeting in San Francisco, October 24 – 29, 2008.

126.  Mease P, Pangan AL, Deodhar AA, Khan MA, Rosenbaum JT, van der Heijde D, Sieper J, Combescure C, Dougados M. Characterization of Spondyloarthritis Diagnoses and Patient Satisfaction with Current Treatments in the US: Report from the SPARK Survey. ACR Annual Meeting in Philadelphia, 2009.

127.  Kiltz U, van der Heijde, Boonen A, Cieza A, Stucki G, Khan MA, et al. Development of a Health Index to Assess the Burden of Disease in Patients with Ankylosing Spondylitis: First Steps of a Global Initiative Based on the ICF Guided by ASAS. Abstract # OP0251. Presented at the Annual European Congress of Rheumatology EULAR 2012, Berlin, Germany, 6 – 9 June, 2012.

128.  Bao C, Huang F, Khan MA, Fei K, Wu Z, Hsia EC. Golimumab Administered Subcutaneously Every 4 Weeks in Chinese Patients with Active Ankylosing Spondylitis: Week 24 Safety and Efficacy Results From a Randomized, Placebo-Controlled Study. Presented at the 15th Congress of Asia-Pacific League Against Rheumatism APLAR 2012. Dead-Sea, Amman, Jordan, 10-14 September, 2012.

129.  Bao C, Huang F, Khan MA, Fei K, Wu Z, Hsia EC. Golimumab Administered Subcutaneously Every 4 Weeks in Chinese Patients with Active Ankylosing Spondylitis: Week 24 Safety and Efficacy Results From a Randomized, Placebo-Controlled Study. Presentation at 2012 ACR Annual Meeting, Washington, D.C., November 9-14, 2012.

Arthritis Rheum 2012; vol 63, No: 10 (suppl), p S589.

130.  Magrey M, Khan MA. Utility of Dual-Energy X-Ray Absorptiometry Scanning and Risk of Osteoporosis in Ankylosing Spondylitis; A Prospective Study. Presentation at 2012 ACR Annual Meeting, Washington, D.C., November 9-14, 2012.

Arthritis Rheum 2012; vol 63, No: 10 (suppl), p S243-S244.

131.  Kiltz U, van der Heijde D, Boonen A, Cieza A, Stucki G, Khan MA, et al. Development of a Health Index for Patients with Ankylosing Spondylitis. Presented at 2012 ACR Annual Meeting, Washington, D.C., November 9-14, 2012. Arthritis Rheum 2012; vol 63, No: 10 (suppl), p S593-594.

132.  Bao C, Huang F, Khan MA, Fei K, Wu Z, Hsia EC. Safety and Efficacy of Golimumab in Chinese Patients with Active Ankylosing Spondylitis 1- year Result of a Multicenter Randomized, Double-blind, Placebo-Controlled Study. 2013 EULAR (European Congress of Rheumatology) Annual Scientific meeting. June 14, 2013 in Madrid, Spain. And 2013 ACR Annual Scientific meeting. October 30, 2013 in San Diego, USA.

133.  Kiltz U, van der Heijde D, Boonen A, Cieza A, Stucki G, Khan MA, et al. Development of a Health Index in Patients with Ankylosing Spondylitis (ASAS HI) – Final Results of a Global Initiative Based on the ICF Guided by ASAS. 2013 EULAR (European Congress of Rheumatology) Annual Scientific meeting. June 14, 2013 in Madrid, Spain. And 2013 ACR Annual Scientific meeting. Abstract # 2836. October 30, 2013 in San Diego, USA.

134.  Kiltz U, van der Heijde, Boonen A, Cieza A, Stucki G, Khan MA, et al. Translation and cross-cultural adaptation of the ASAS Health Index and the Environmental Item set into 15 languages. Presented at the Annual European Congress of Rheumatology EULAR 2014, Paris, France. June 11-14, 2014.

135.  Kiltz U, van der Heijde D, Boonen A, Bautista W, --------, Khan MA, et al. Translation and cross-cultural adaptation of the ASAS Health Index and the Environmental Item set into 15 languages. Presented at the 9th International Congress of Spndyloarthropathies. Gent, Belgium, October 23-25, 2014

136.  Magrey M, Lewis S, Khan MA. Do the validated tools of disease and functional activity in ankylosing spondylitis measure fibromyalgia symptoms? Presented  at the Annual European Congress of Rheumatology EULAR 2016, London, England. June 8-11, 2016.

137.  Magrey M, Lewis S, Khan MA. Do validated tools of disease activity in ankylosing spondylitis measure fibromyalgia pain? Presented at the 2016 ACR Annual Meeting, Washington, D.C., November 11-16,  2016.

138.   van der Linden, Rentsch H, Baumberger H, Khan MA. Specificity of spinal pain features in assessment and classification of spondyloarthriis. Presented at the 2016 ACR Annual Meeting, Washington, D.C., November 11-16,  2016.

139.  Baumberger H, Khan MA.  Gradual progressive change to equal prevalence of ankylosing spondylitis among males and females in Switzerland: Data from the Swiss Ankylosing Spondylitis Society (SVMB). Ann Rheum Dis 2017;76:529.  (Presented  at the Annual European Congress of Rheumatology EULAR 2017, Madrid, Spain. June 14-17, 2017. Ann Rheumatic Dis. 2017; volune 76; suppl. 2; page 929.)

140.  van der Linden, Villiger P, Boonen A, Brown MA,,Baumberger H, Khan MA. The occurrence of ankylosing spondylitis (AS) among relatives of probands with radiographic AS and non-radiographic AS/axial spondyloarthritis (SpA). (Presented  at the Annual European Congress of Rheumatology EULAR 2017, Madrid, Spain. June 13-16, 2018.  


WEB SITE:  www.spondyloarthritis-international.org      or  www.HLAB27.com

ONLINE PUBLICATIONS:

Khan MA: Editorial Consultant to American College of Physicians’ on-line ACP Smart Medicine (formerly called Physician Information and Education Resource or“PIER”) since 2002, and

author of the chapter “Ankylosing Spondylitis” and its updates from 2002 to 2015. www.smartmedicine.acponline.org

 Khan MA: Editorial Consultant  2013-2016  to InPractice Rheumatology, an on-line knowledge source for internists, including rheumatologists.

Co-author of the chapter on “Spondyloarthritis”.

        

Medscape: Expert Column: Ankylosing spondylitis. Posted 09/28/2006.  http://www.medscape.com/viewarticle/544971

Medscape: EUAR 2007: The Annual European Congress of Rheumatology. Ankylosing Spondylitis. An Update From EULAR 2007. http://www.medscape.com/viewarticle/560593

Medscape: EUAR 2007: The Annual European Congress of Rheumatology. Psoriatic Arthritis: An Update From EULAR 2007. http://www.medscape.com/viewarticle/560594

Medscape: Online CME activity. Release Date: May 27, 2008; Valid for credit through May 27, 2009. Khan MA, Elyan M. The Many Faces of Ankylosing Spondylitis: Evidence-Based Approach to Diagnosis and Management, http://www.medscape.com/viewprogram/12637

Medscape: American College of Rheumatology (ACR) 2008 Annual Scientific Meeting. Spondyoarthropathies: Treatment Advances from ACR 2008, http://www.medscape.com/viewarticle/585026




INVITED SPEAKER / PARTICIPANT
AT NATIONAL AND  INTERNATIONAL SCIENTIFIC MEETINGS:


1.      First International Symposium on HLA and Disease. Predisposition to disease and clinical implications. Palais des Congrés, Porte Maillot, Paris, France. June 23-25, 1976

2.      15th International Congress of Rheumatology (ILAR). Paris, France. June 21-27, 1981 (Revue du Rheumatisme. Abstracts. June 1981).

3.      The Annual Scientific Meeting of the Australian Rheumatism Association in conjunction with D‑PEN - HLA 1982 “Immunogenetics in Rheumatoloy: D-Penicillamine & Musculoskeletal Diseases” ). Perth, Australia, April 14-22, 1982

4.      All India Institute of Medical Sciences, New Delhi, India, April 28, 1982

5.      5th International Congress of Eye Research, Eindhoven, The Netherlands, October 3‑8, 1982

6.      International Symposium on “Pathogenesis of HLA‑B27 Associated Diseases”. Middlesex Hospital Medical School, London, England, April 12‑13, 1983

7.      National Institute of Health Consensus Development Conference on Prevention of Arthritis. Airlie House, near Washington, DC, July 19‑22, 1983

8.      International Conference on Spondyloarthropathies.  The University of Texas Health Science Center at Dallas, Texas, May 31‑June 1, 1984

9.      9th Yugoslav Congress of Rheumatology.  Zagreb, Yugoslavia, September 19‑23, 1984

10.  Symposium on Current Immunological Concepts in Rheumatology‑Immunopathology, Genetics and Therapy.  Budapest, Hungary, September 26‑28, 1984

11.  Current Concepts in Rheumatology and Worldwide Experience with Voltaren. Rose Hall Resort, Jamaica, November 29‑December 4, 1984

12.  Spondyloarthropathy Symposium. Leiden, The Netherlands, May 9‑10, 1985

13.  Ohio Academy of Family Physicians Annual Meeting, Family Physician Workshop. Columbus, Ohio, January 26, 1986

14.  European League Against Rheumatism (EULAR) Symposium on Seronegative Polyarthritis.  Rome, Italy, October 16‑18, 1986

15.  2nd International Symposium on the Pathogenesis of Ankylosing Spondylitis and Rheumatoid Arthritis.  London, England, April 14‑15, 1987

16.  Ankylosing Spondylitis Symposium. Leukerbad, Switzerland, September 25, 1987

17.  International Symposium on Spondyloarthropathies, organized by the Mexican Society of Rheumatology.  Mexico City, Mexico, September 30 & October 1, 1988

18.  1st Canadian Ankylosing Spondylitis Symposium (Ontario Spondylitis Association). Toronto, Canada, May 13, 1989

19.  1st  International Meeting of the Ankylosing Spondylitis International Federation (ASIF)., Leukerbad, Switzerland, July 7‑10, 1989

20.  17th ILAR (International League Against Rheumatism) Congress of Rheumatology.  Rio de Janeiro, Brazil, September 17‑23, 1989

21.  Annual Meeting of the Mexican Society of Rheumatology.  Mexico City, Mexico, October 24, 1989

22.  5th Bertine Koperberg Conference, "The Pathogenetic Role of the HLA‑B27".  Oosterbeek near Arnhem, The Netherlands, May 22‑23, 1990

23.  Annual Meeting of the Rheumatism Association of the Republic of China.  Taipei, Taiwan, November 23‑24, 1990

24.  1st AFLAR Congress of Rheumatology (African League Against Rheumatism), Cairo, Egypt, September 23‑27, 1991

25.  1st Scientific Meeting of the Japan Ankylosing Spondylitis Society, Osaka, Japan, October 12, 1991

26.  Rheumatic Diseases Meeting, Banff, Alberta, Canada, October 24‑26, 1991

27.  "Meet the Professor" speaker at the ACR Annual Scientific Meeting, Boston MA, November 18‑20, 1991; and chaired the session on Spondyloarthropathies.

28.  7th APLAR (Asian and Pacific League Against Rheumatism) Congress of Rheumatology, Bali, Indonesia, September 14‑18, 1992.

29.  National Arthritis Foundation Oration at "Living with Arthritis Seminar", Singapore, September 19, 1992.

30.  Singapore Society of Immunology, Allergy and Rheumatology "Rheumatology Review – 1992”. Singapore, September 19‑20, 1992.

31.  "Meet the Professor" speaker at the ACR Annual Scientific Meeting, Atlanta, GA, 1992; and chaired the Spondyloarthropathy Study Group.

32.  Symposium and Workshop on "Spondyloarthropathies & HLA‑B27, at Sestroretsk Spa in St. Petersburg, Russia, October 27‑31, 1992.

33.  3rd International Symposium on Ankylosing Spondylitis, London, England, March 30‑31, 1993.

34.  International Conference on Spondyloarthropathies and the Gut, Ghent, Belgium, July 1-2, 1993.

35.  18th Congress of the International League Against Rheumatism, Barcelona, Spain, July 4-9, 1993.

36.  5th Annual Joseph Lee Hollander Lecturer, at the Eighth Annual Clinical Update in Rheumatology, University of Pennsylvania, Philadelphia, September 21, 1993,

37.  "Meet the Professor" speaker at the ACR Annual Scientific Meeting, San Antonio, TX,  1993

38.  International Symposium on HLA in Health and Disease: Current State of the Art, New Delhi, India, December 6-8, 1993.

39.  15th Sigrid Juselius Symposium: Arthritis and Autoimmunity, Turku, Finland, May 25-29, 1994.

40.  25th Scandinavian Congress of Rheumatology, Lillehammer, Norway, June 1-4, 1994.

41.  "Meet the Professor" speaker at the ACR Annual Scientific Meeting, Minneapolis, MN,  1994

42.  13th European Congress of Rheumatology, Amsterdam, Holland, June 18-24, 1995.

43.  2nd Conference on the Pathogenetic Role of HLA-B27. Amsterdam, Holland, August 30 - Sept. 2, 1995.

44.  Delivered The Brook Haywood Lecture at the Biennial Congress of the South African Rheumatism and Arthritis Association, Johannesburg, South Africa, September 3-6, 1995       

45.  8th Congress of the Asia Pacific League of Associations for Rheumatology (APLAR), CommunitySymposium. Melbourne, Australia, April 21-26, 1996

46.  Speaker at the ACR/AHP Annual Scientific Meeting, ‘Professionals who are also patients’. Orlando, October 21, 1996.

47.  International Congress on Physical Medicine and Rehabilitation, Ankara, Turkey, May 15-18, 1997.

48.  International Society for the Study of the Lumbar Spine, Management of Low Back Pain Course, Singapore, June 6-8, 1997.

49.  19th Congress of the International League of Associations in Rheumatology [ILAR], Singapore, June 9-13, 1997.

50.  Pakistan Society of Rheumatology Annual Scientific Meeting, Islamabad, Pakistan. November 21-22, 1997.

51.  5th Encontro de Reumatologia Advancada, Sao Paulo, Brazil, June 5-6, 1998.

52.  International Congress on Physical Medicine and Rehabilitation, Antalya, Turkey, May 16-20, 1999.

53.  4th International Workshop on Reactive Arthritis, Berlin, Germany, July 2-6, 1999.

54.  Symposium on Enthesitis and Ankylosis in Spondyloarthropathy. Held at Klinikum Benjamin Franklin in Berlin, Germany, on February 25-26, 2000.

55.  Speaker at Scientific Symposium on the occasion of award ceremony of Carol-Nachmann Prize in Rheumatology, for the year 2000 to Jochem Sieper and Jurgen Braun, held in Wiesbaden, Germany, on May 5, 2000.

56.  11th National Rheumatology Congress of the Tunisian League Against Rheumatism, Tunis, Tunisia, May 13-14, 2000.

57.  9th APLAR Congress 2000 (The Asia Pacific League of Associations for Rheumatology), Beijing, China, May 21-26, 2000.

58.  2nd International Congress on Spondyloarthropathies (and Member of the Scientific Committee of the Congress).Gent, Belgium, October 4-7, 2000.

59.  Annual Scientific Meeting of the Turkish Rheumatology Association, Antalya, Turkey, October 18-21, 2000.

60.  Annual (64th) ACR Scientific Meeting (The American College of Rheumatology), Philadelphia, PA, October 28 to November 2, 2000; and also received the ACR’s “Distinguished Rheumatologist Award” for the year 2000.

61.  Kompetenznetz Rheuma, 2nd International Symposium, Bamberg, Germany, March 8-10, 2001.

62.  2nd EULAR (The European League of Associations for Rheumatology) Congress 2001. Prague, Czech Republic, June 13-16, 2001.

63.  The annual Joint Conference of the Swiss Society of Rheumatology and the Swiss Society of Physical Medicine and Rehabilitation, held in Aarau, Switzerland, from September 6-7, 2001.

64.  Argentina Rheumatology Society Annual Scientific Meeting, held in Buenos Aires, Argentina, October 6-8, 2001.

65.  International Symposium on Spondyloarthropathy, held in Cordoba, Spain, October 15, 2001.

66.  Irish Society for Rheumatology Annual Scientific Meeting, held in Dublin, Ireland, October 19, 2001.

67.  International Symposium on anti-TNF therapy in Spondyloarthropathy, Berlin, Germany, January 18-20, 2002.

68.  7th International Conference on Rheumatic Diseases, and the Annual Scientific Meeting of the Pakistan Society of Rheumatology, Lahore, Pakistan, February 9-10, 2002.

69.  International Symposium on Enthesitis in Spondyloarthropathies, Leeds, UK, March 15-17, 2002.

70.  1st Pan Arab and 6th Jordanian Internal Medicine Conference, Amman, Jordan, April 19-23, 2002.

71.  12th Annual Cleveland Review of Rheumatic Diseases, Cleveland, OH, May 3-4, 2002.

72.  8th PANLAR (Pan‑American League of Associations Rheumatology) Congress, Aruba, June 23-27, 2002.

73.  North American Ankylosing Spondylitis Investigators Meeting, New York, NY, August 26-28, 2002.

74.  29th Scandinavian Congress of Rheumatology, Tromso, Norway, August 15-18, 2002.

75.  3rd International Congress on Spondyloarthropathies, Gent, Belgium, October 2-5, 2002.

76.  66th ACR Annual Scientific Meeting, Organizer and Moderator of the ACR Pre-Conference Review Course, New Orleans, LA. October 24, 2002.

77.  Guidance Document Meeting on Ankylosing Spondylitis. Bethesda, Maryland. October 29-31, 2002

78.  Ankylosing Spondylitis Assessment (ASAS) Meeting, Berlin, Germany, January 24-25, 2003.

79.  Canadian Rheumatology R.A.D.I.O. Meeting, Scottsdale, Arizona, March 29-30, 2003.

80.  Entering a new Era in the Management of Ankylosing Spondylitis: The Role of Infliximab. Barcelona, Spain, May 23-24, 2003.

81.  United States Consensus Guidelines for the Use of Anti-TNF Therapy in Patients with Spondylitis Meeting, San Francisco, CA June 1-2, 2003.

82.  4th EULAR Congress 2003 (The European League of Associations for Rheumatology), Lisbon, Portugal, June 19-22, 2003.

83.  Organizational Meeting for the AS-US Working Group, Salt Lake City, Utah, August 8-10, 2003.

84.  Psoriatic Arthritis Working Group Consensus Conference, New York, NY. August 15-17, 2003.

85.  Current Issues in the Spondyloarthropathies. Houston, Texas, September 13, 2003

86.  67th ACR Annual Scientific Meeting, Organizer and Moderator of the ACR Pre-Conference Review Course, Orlando, FL. October 24, 2003

87.  ASAS (ASsessment in Ankylosing Spondylitis) International Meeting, Washington, DC (Bethesda). January 16-18, 2004.

88.  2nd Annual National Advocacy Meeting of the Oregon Rheumatology Alliance, Portland, Oregon, USA, February 27-28, 2004

89.  7th National Annual Scientific Meeting of the Italian College of Rheumatologists, Maratea, Italy, April 16-18, 2004.

90.  2nd Pan Arab and 7th Jordanian Internal Medicine Conference, Amman, Jordan, April 25-29, 2004.

91.  Annual Scientific Meeting of the Turkish Rheumatic Diseases Congress, Antalya, Turkey, April 27-29, 2004.

92.  14th Annual Cleveland Review of Rheumatic Diseases, Cleveland, OH, April 30-May 1, 2004.

93.  2nd Annual Meeting of Spondyloarthritis Research and Treatment Network (SPARTAN): Advances in AS and SpA Research and Patient Care. Los Angeles, CA, July 30-31, 2004.

94.  Hot Topics in Rheumatology and Infectious Diseases, Nemacolins Woodland Conference Center, Farmington, PA, September 18-19, 2004.

95.  4th International Congress of Spndyloarthropathies, Gent, Belgium, October, 2004

96.  68th ACR Annual Scientific Meeting, Organizer and Moderator of the ACR Pre-Conference Review Course, San Antonio, TX, October, 2004.

97.  3rd Huaxia Congress on Diagnosis and Management of Rheumatic Diseases, Taipei, Taiwan, December 11-12, 2004.

98.  21st Annual “Rheumatology on the Beach” Meeting, Destin, Florida, March 19 to March 22, 2005. Received the "Outstanding Speaker Award" of The Arthritis Foundation (Alabama Chapter).

99.  5th Annual Congress of the Egyptian Society of Back Pain. In Collaboration with Pan Arab Congress of back Pain. Cairo, Egypt, April 27-29, 2005. 

100.  2nd State of the Art in Chronic Low Back Pain symposium. Bodrum, Turkey, May 10-13, 2005.

101.  3rd Annual Scientific Meeting of Spondyloarthritis Research and Treatment Network (SPARTAN): San Francisco, CA, August 12-14, 2005.

102.  3rd International Enthesitis Meeting, and Advanced Course on Spondyloarthritis. Matera, Italy, September 29 to October 1, 2005.

103.  ASAS (ASsessment in Ankylosing Spondylitis) International Meeting, Paris, France, January 13-14, 2006.

104.  International Spondyloarthritis Validation Study Meeting, held in Toronto, Canada. January; 28-29, 2006. 

105.  International Symposium on Improving Outcomes in the Treatment of Spondyloarthropathies, held in Monte Carlo, Monaco, February 24-25, 2006.

106. “Spondyloarthritis 2006: The Unmet Needs” Conference at NIH; organized by NIAMS and Spondylitis Association of America, Held at the NIH campus in Betheda, Maryland, USA; March 30-31, 2006.

107. 16th Annual Cleveland Review of Rheumatic Diseases, Cleveland, OH, April 21-22, 2006.

108. Annual Scientific Meeting of the Turkish Rheumatic Diseases Congress, Antalya, Turkey, April 26-28, 2006.

109. Annual Meeting of the Ontario Rheumatology Association, Taboo Resort, Gravenhurst, Ontario, Canada, May 13, 2006.

110. Scientific Meeting of the Lithuanian Rheumatology Association, Kaunas, Lithuania, May 18, 2006.

111. Korean Research Council of Rheumatism, Rheumatology Board Review Course. Seoul, South Korea, June 17, 2006

112. Annual European Congress of Rheumatology- EULAR 2006, Amsterdam, The Netherlands, June 21-24, 2006

113. Combined Annual meeting of American Spinal Injury Association (ASIA) and International Spinal Cord Society of Paraplegia (ISCoS), Boston, MA, June 24-28, 2006

114.  12th Asian Pacific League for Rheumatology Congress - APLAR 2006, Asian Rheumatology “facing the Challenges”. Kuala Lumpur, Malaysia, August 1-5, 2006

115.  14th Pan American League of Associations for Rheumatology - PANLAR 2006, Lima, Peru, August 19-23, 2006

116.  Annual Turkish Rheumatology Congress, Cesme (Izmir), Turkey, September 1-4, 2006

117. Delivered the 56th Pemberton Lecture, Philadelphia Rheumatism Society Meeting. Philadelphia, PA. October 10, 2006

118. 5th International Congress of Spndyloarthropathies (and Member Scientific Committee) , Gent, Belgium, October 12-14, 2006

119.  ACR Annual Scientific Meeting “Meet the Professor" speaker, Washington, DC, November 11-14, 2006

120. ACR 2006 Satellite Symposium speaker “Changing the Treatment of Rheumatic Diseases: Optimal use of Biological Therapy”, Washington, DC, November 12, 2006

121.  14th Annual Convention  of the Philippine Rheumatology Association, Cagayan de Oro, Philippines, January 25-27 2007

122.  Visiting Professor, University of Santo Tomas, Manila, Philippines, January 28, 2007

123.  Arab Health Congress 2007. Dubai, United Arab Emirate, January 31 – February 1, 2007

124.  Memorial University of Newfoundland, St. John’s, Newfoundland, Canada. February 5-6, 2007

125.  11th International Conference on Rheumatic Diseases, and the Annual Scientific Meeting of the Pakistan Society for Rheumatology, Karachi, Pakistan, March 4-6, 2007

126.  17th Annual Cleveland Review of Rheumatic Diseases, Cleveland, OH, April 20-21, 2007

127.  4th MENA (Middle East and North Africa) RA Summit, Casablanca, Morocco, May 16 – 19, 2007

128.  Puerto Rican Rheumatologists Association International Meeting (PRAIM), San Juan, Puerto Rico, May 25 - 27, 2007

129.  Colombian Rheumatology Association Annual Meeting, Medellin, Colombia, August 17 - 19, 2007

130.  7th  Annual Rheumatology Conference Update 2007 – New Perspective in the Management of the Rheumatic Diseases: Applying Research to Practice. Hollywood, Florida. September 8, 2007

131.  5th Annual Scientific Meeting of  Spondyloarthritis Research and Treatment Network (SPARTAN): Cleveland, OH, September 14-15, 2007

132.  Biologic Revolution in the Treatment of Rheumatic Diseases. King Fahd Medical City, Riyadh, Saudi Arabia. October 23-24, 2007

133.  ACR Annual Scientific Meeting "Meet the Professor" speaker, Boston, MA, November 7 - 11, 2007

134.  4th Huaxia Congress on Diagnosis and Management of Rheumatic Diseases, Hong Kong, China, December 7- 9, 2007

135.  8th Pan Arab Rheumatology Society Conference, Doha, Qatar, January 21 – 24, 2008

136.  Arab Health Congress 2008. Dubai, United Arab Emirate, January 28 - 31, 2008

137.  12th International Conference on Rheumatic Diseases, and the Annual Scientific Meeting of the Pakistan Society for Rheumatology, Rawalpindi, Pakistan, March 28-30, 2008

138. 18th Annual Cleveland Review of Rheumatic Diseases, Cleveland, OH, April 18-19, 2008

139.  6th Annual Scientific Meeting of Spondyloarthritis Research and Treatment Network (SPARTAN): Cleveland, OH, July 25,26, 2008

140.  15th Pan American League of Associations for Rheumatology- PANLAR 2008, Guatemala City, Guatemala, August 12-16, 2008

141.  GRAPPA 2008 Meeting (Group for Research and Assessment of Psoriasis and Psoriatic Arthritis), Leeds, UK  September 5-7, 2008

142.  6th International Congress of Spondyloarthropathies (and Member Scientific Committee), Gent, Belgium, October 2-4, 2008.

143.  ACR Annual Scientific Meeting "Meet the Professor" speaker, San Francisco, CA, October 24 – 29, 2008

144.  University of Louisville, Department of Medicine Grand Rounds, Louisville, KY, February 5, 2009

145. 13th Annual Scientific Meeting of the Pakistan Society for Rheumatology, Lahore, Pakistan, March 6-8, 2009

146.  Arab Health Rheumatology Conference 2009. Dubai, United Arab Emirate, March 18 – 19, 2009

147.  Visiting Professor, Sichuan University, West China Hospital /West China School of Clinical Medicine, Chengdu, China, March 20 – 25, 2009

148.  Southern California Rheumatology Society Meeting, Los Angeles, March 31, 2009

149. 7th Annual Scientific Meeting of Spondyloarthritis Research and Treatment Network (SPARTAN), HLA-B27 and Genetics Meetings; Houston TX, July 23-25, 2009

150. 8th Annual Scientific Meeting of Spondyloarthritis Research and Treatment Network (SPARTAN); Houston TX, July 22-24, 2010

151. 7th International Congress of Spndyloarthropathies (and Member Scientific Committee) , Gent, Belgium, October 7-9, 2010

152. GRAPPA 2010 Meeting (Group for Research and Assessment of Psoriasis and Psoriatic Arthritis), Miami Beach, Florida. December 8-11, 2010

153.  21st Annual International Conference on Family Medicine, Lahore, Pakistan, January 14-16, 2011

154.  ASAS (ASsessment in Ankylosing Spondylitis) International Meeting, Brussels, Belgium, January 21-23, 2011

155. 10th Annual Rheumatic Disease Conference, Santa Fe, NM, April 29-30, 2011

156.  9th Annual Scientific Meeting of Spondyloarthritis Research and Treatment Network (SPARTAN); Portland, OR, July 22-24, 2011

157.  ACR Annual Scientific Meeting, Chicago, IL, November 4 – 9, 2011

158. Visiting Professor. The University of Toronto, Division of Rheumatology, Toronto, Canada, January 9 – 10, 2012

159.  8th Annual Robert Inman Lecturer, Toronto, Canada, January 10, 2012

160.  5th Turkish Congress of Rheumatology Meeting. Antalya, Turkey, March 27-31, 2012

161.  Symposium on the “Last 2 Years in Rheumatology”, Izmir, Turkey, March 29 – April 1, 2012

162.  17th Pan American League of Associations for Rheumatology- PANLAR 2012, Punta Cana, Dominican Republic, April 18-21, 2012

163.  13th Malaysian Society of Rheumatology and Singapore Society of Rheumatology Workshop in Rheumatology, “Pearls and Practicalities in Rheumatology”. Penang, Malaysia, July 6-8, 2012

164. 10th Annual Research and Education Meeting of Spondyloarthritis Research and Treatment Network (SPARTAN) and GRAPPA (Group for Research and Assessment of Psoriasis and Psoriatic Arthritis); (in conjunction with SPARCC (SpA Research Consortium of Canada) and PANLAR). Portland, OR, July 27-28, 2012

165. 2nd Latin American Summit of Spondyloarthritis. Bogota, Colombia, August 24-25, 2012

166. 15th Congress of Asia-Pacific League Against Rheumatism APLAR 2012. Dead Sea, Amman, Jordan, September 10 - 14, 2012

167.  8th International Congress of Spndyloarthropathies. Gent, Belgium, October 4-6, 2012

168.  International Pathology Symposium 2012. Riyadh, Saudi Arabia, November 24-28, 2012

169.  New Jersey Rheumatology Association Meeting. West Orange, New Jersey, January 7, 2013

170.  Hong Kong Society of Rheumatology Scientific Symposium, Hong Kong, China. April 23, 2013

171.  2013 Taiwan Rheumatology Association, Spring Meeting. Taichung, Taiwan, April 26-28, 2013

172. 14th Annual Turkish Rheumatology Congress, Cesme (Izmir), Turkey, September 115, 2013

173.  ASAS International Meeting, Dusseldorf, Germany, January 17-18, 2014

174. 14th Annual International Congress of the Egyptian Society of Back Pain. In Collaboration with World Federation of Neurorehabilitation. Cairo, Egypt, January 29-31, 2014

175.  Cleveland Clinic, Medical Division Grand Rounds, Cleveland, OH, March 13, 2014

176. 18th Annual Scientific Meeting of the Pakistan Society for Rheumatology, Rawalpindi, Pakistan, Meeting, April 11 - 13, 2014

177.  American College of Rheumatology (ACR) Annual State-of-the-Art (SOTA) Clinical Symposium, Chicago, IL, April 26 – 27, 2014

178.  12th Research and Education Meeting of Spondyloarthritis Research and Treatment Network (SPARTAN) in conjunction with GRAPPA (Group for Research and Assessment of Psoriasis and Psoriatic Arthritis). New York, NY, July 10-13, 2014

179.  9th International Congress of Spndyloarthropathies. Gent, Belgium, October 23-25, 2014

180.  ASAS International Meeting, Madrid, Spain. January 16-17, 2015

181.  19th Annual Scientific Meeting of the Pakistan Society for Rheumatology, Lahore, Pakistan. April 10 - 12, 2015

182. 13th Annual Scientific Research and Education Meeting of Spondyloarthritis Research and Treatment Network (SPARTAN). Denver, Colorado. July 25-26, 2015

183.  10th Annual Meeting of the Ohio Association of Rheumatology, Columbus, Ohio. August 28-29, 2015

184.  9th Annual Washington Rheumatology Alliance Conference, Leavenworth, WA. September 19-20, 2015

185. ASAS International Meeting, Berlin,, Germany. January 22-23,, 2016

186.  2nd Annual Meeting of the Rheumatology Association of Iowa, Cedar Rapids,, Iowa. March 11-12, 2016

187.  7th Annual Meeting of the Turkish Rheumatology Association, Antalya, Turkey, March 16-20, 2016

188.  19th Pan American League of Associations for Rheumatology Congress - PANLAR 2016, Panama City, Panama, April 10-14, 2016

189.  14th Annual Scientific Research and Education Meeting of Spondyloarthritis Research and Treatment Network (SPARTAN). Denver, Colorado. July 21-24, 2016

190. Annual Meeting of the Kentucky Association of Rheumatology, Lexington, Kentucky. October 21-22, 2016

191. ASAS International Meeting, Leeds. UK. January 20-21, 2017

192.  Visiting Professor, Loma Linda University, Loma Linda, California. April 11-12, 2017

193.  Lake Health Rheumatology Symposium, Eastlake, Ohio. April 26, 2017

194.  15th Annual Scientific Research and Education Meeting of Spondyloarthritis Research and Treatment Network (SPARTAN). Denver, Colorado. July 21-24, 2016

195. 15th Annual Scientific Research and Education Meeting of Spondyloarthritis Research and Treatment Network (SPARTAN). Boston, MA. May 2-5, 2017

196. Annual European Congress of Rheumatology EULAR 2017,and ASAS Meeting. Madrid, Spain. June 14-17, 2017

197.  GRAPPA Annual Meeting, Amsterdam, Holland, July 13-15, 2017

198. Spondyloarthritis 2017: Unmet Needs Conference III. Sponsored by  Spondylitis Association of America (SAA) and NIAMS/NIH Bethesda, Maryland, September 13-14, 2017

199.  SPARTAN-GRAPPA Symposium, Cleveland, Ohio. September 23, 2017

200. ASAS International Meeting, Lisbon, Portugal. January 19-20, 2018

201. 16th Annual Scientific Research and Education Meeting of Spondyloarthritis Research and Treatment Network (SPARTAN). Boston, MA. May 2-5, 2018

202. Annual European Congress of Rheumatology EULAR 2017, and ASAS and GRAPPAMeetings, Amsterdam, The Netherlands, June 13-16, 2018

203. GRAPPA Annual Meeting, Toronto, Canada, July 12-14, 2018

204. Chicago Rheumatism Society 2018 Educational Conference, Chicago, August 22, 2018

205. 13th ASIF (Ankylosing Spondylitis International Federation) Meeting, Guangzhou, October 10-13, 2018



 

Site meter

Minimize
hit counter
Login    Prof. Dr. Muhammad Asim Khan   Terms Of Use  Privacy Statement    .| Site Meter